Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Palliative Care | 69 | 2017 | 3598 | 6.870 |
Why?
|
Medical Oncology | 41 | 2017 | 2321 | 3.750 |
Why?
|
Occupational Exposure | 70 | 2017 | 1813 | 3.570 |
Why?
|
Air Pollutants, Occupational | 52 | 2012 | 407 | 3.170 |
Why?
|
Neoplasms | 95 | 2020 | 22170 | 3.040 |
Why?
|
Hospice Care | 17 | 2017 | 678 | 2.950 |
Why?
|
Glutamate Dehydrogenase | 14 | 2009 | 50 | 2.550 |
Why?
|
Vehicle Emissions | 28 | 2017 | 656 | 2.270 |
Why?
|
Motor Vehicles | 14 | 2017 | 282 | 2.000 |
Why?
|
Rhinovirus | 22 | 2009 | 203 | 1.930 |
Why?
|
Hospices | 7 | 2017 | 245 | 1.580 |
Why?
|
Terminal Care | 18 | 2017 | 1760 | 1.560 |
Why?
|
Physician-Patient Relations | 20 | 2016 | 3249 | 1.550 |
Why?
|
Carbon | 15 | 2017 | 666 | 1.470 |
Why?
|
Pain, Intractable | 6 | 2011 | 132 | 1.430 |
Why?
|
Infusion Pumps, Implantable | 7 | 2005 | 158 | 1.400 |
Why?
|
Nitrosamines | 23 | 2003 | 87 | 1.360 |
Why?
|
Occupational Diseases | 43 | 2012 | 1490 | 1.340 |
Why?
|
Lung Neoplasms | 55 | 2017 | 13380 | 1.250 |
Why?
|
Dog Diseases | 7 | 2009 | 141 | 1.210 |
Why?
|
Environmental Monitoring | 27 | 2017 | 1460 | 1.200 |
Why?
|
Health Care Costs | 20 | 2017 | 3242 | 1.110 |
Why?
|
Truth Disclosure | 7 | 2016 | 434 | 1.060 |
Why?
|
Capsid | 18 | 2014 | 435 | 1.060 |
Why?
|
Antineoplastic Agents | 32 | 2015 | 13639 | 1.060 |
Why?
|
Cost-Benefit Analysis | 36 | 2017 | 5492 | 1.010 |
Why?
|
Capsid Proteins | 12 | 2018 | 468 | 1.000 |
Why?
|
Norovirus | 5 | 2018 | 37 | 0.990 |
Why?
|
Anticarcinogenic Agents | 11 | 2001 | 250 | 0.970 |
Why?
|
Carcinogens | 21 | 2002 | 452 | 0.970 |
Why?
|
Breast Neoplasms | 49 | 2017 | 21012 | 0.970 |
Why?
|
Oxygenases | 9 | 2007 | 59 | 0.960 |
Why?
|
Medical Futility | 4 | 2015 | 136 | 0.950 |
Why?
|
Forelimb | 6 | 2009 | 116 | 0.950 |
Why?
|
Pain | 11 | 2015 | 5073 | 0.950 |
Why?
|
Bacteroides | 3 | 2010 | 165 | 0.940 |
Why?
|
Glass | 7 | 2005 | 115 | 0.930 |
Why?
|
Humans | 498 | 2020 | 761504 | 0.930 |
Why?
|
Antibodies, Viral | 15 | 2014 | 3156 | 0.860 |
Why?
|
Referral and Consultation | 14 | 2017 | 3600 | 0.860 |
Why?
|
Advance Care Planning | 5 | 2015 | 698 | 0.860 |
Why?
|
Immunoglobulin Fab Fragments | 13 | 2010 | 445 | 0.860 |
Why?
|
Diphenhydramine | 2 | 2014 | 63 | 0.860 |
Why?
|
Granulocyte Colony-Stimulating Factor | 6 | 2012 | 629 | 0.860 |
Why?
|
Colony-Stimulating Factors | 5 | 2012 | 218 | 0.850 |
Why?
|
Lorazepam | 2 | 2014 | 154 | 0.810 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 10 | 2001 | 318 | 0.790 |
Why?
|
Virginia | 22 | 2014 | 116 | 0.790 |
Why?
|
Drug Costs | 8 | 2015 | 1183 | 0.770 |
Why?
|
Haloperidol | 2 | 2014 | 389 | 0.770 |
Why?
|
Antiemetics | 2 | 2014 | 186 | 0.760 |
Why?
|
Models, Molecular | 35 | 2010 | 5439 | 0.760 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 24 | 2016 | 5315 | 0.750 |
Why?
|
Viral Proteins | 11 | 2007 | 1804 | 0.740 |
Why?
|
Attitude of Health Personnel | 10 | 2016 | 3889 | 0.740 |
Why?
|
Patient Care Planning | 3 | 2016 | 908 | 0.730 |
Why?
|
Drug Therapy | 5 | 2013 | 503 | 0.720 |
Why?
|
Filgrastim | 4 | 2015 | 132 | 0.710 |
Why?
|
Adenosine Diphosphate | 10 | 2007 | 422 | 0.700 |
Why?
|
Isothiocyanates | 11 | 2001 | 49 | 0.690 |
Why?
|
Practice Guidelines as Topic | 17 | 2013 | 7390 | 0.690 |
Why?
|
Evidence-Based Medicine | 13 | 2016 | 3688 | 0.680 |
Why?
|
ATP-Binding Cassette Transporters | 3 | 2007 | 563 | 0.670 |
Why?
|
Starch | 3 | 2010 | 79 | 0.670 |
Why?
|
Hot Flashes | 3 | 2015 | 330 | 0.660 |
Why?
|
Bacterial Proteins | 9 | 2010 | 3847 | 0.660 |
Why?
|
Transportation | 4 | 2008 | 217 | 0.650 |
Why?
|
Hospitals, Rural | 5 | 2010 | 176 | 0.650 |
Why?
|
Inhalation Exposure | 9 | 2012 | 432 | 0.650 |
Why?
|
Pain Measurement | 11 | 2016 | 3550 | 0.650 |
Why?
|
Patients' Rooms | 2 | 2009 | 62 | 0.650 |
Why?
|
Virion | 5 | 2007 | 422 | 0.650 |
Why?
|
Respiratory Tract Neoplasms | 4 | 2004 | 56 | 0.640 |
Why?
|
Mycotoxins | 4 | 2002 | 35 | 0.640 |
Why?
|
Electric Stimulation Therapy | 2 | 2016 | 628 | 0.630 |
Why?
|
Facility Design and Construction | 2 | 2009 | 86 | 0.630 |
Why?
|
Polyvinyl Alcohol | 2 | 2008 | 73 | 0.620 |
Why?
|
Analgesics, Opioid | 9 | 2010 | 3808 | 0.620 |
Why?
|
Radiotherapy Dosage | 5 | 2015 | 2898 | 0.620 |
Why?
|
Enzyme Inhibitors | 11 | 2010 | 3712 | 0.620 |
Why?
|
Acrylic Resins | 2 | 2008 | 135 | 0.620 |
Why?
|
Particulate Matter | 13 | 2017 | 2605 | 0.620 |
Why?
|
Communication | 12 | 2016 | 3873 | 0.610 |
Why?
|
Guideline Adherence | 5 | 2015 | 2220 | 0.610 |
Why?
|
Attitude to Health | 3 | 2013 | 2025 | 0.600 |
Why?
|
Terminally Ill | 4 | 2016 | 240 | 0.600 |
Why?
|
Gasoline | 9 | 2012 | 53 | 0.590 |
Why?
|
Peripheral Nervous System Diseases | 2 | 2016 | 710 | 0.590 |
Why?
|
Antigen-Antibody Complex | 5 | 2003 | 510 | 0.590 |
Why?
|
Length of Stay | 13 | 2017 | 6425 | 0.590 |
Why?
|
Quality of Life | 27 | 2017 | 13367 | 0.580 |
Why?
|
Allosteric Regulation | 7 | 2009 | 426 | 0.580 |
Why?
|
Attitude to Death | 5 | 2010 | 400 | 0.580 |
Why?
|
Phenols | 7 | 2009 | 517 | 0.580 |
Why?
|
Middle Aged | 159 | 2020 | 220895 | 0.580 |
Why?
|
Analgesics, Non-Narcotic | 2 | 2011 | 370 | 0.580 |
Why?
|
Bone Neoplasms | 5 | 2015 | 2529 | 0.570 |
Why?
|
Synechocystis | 2 | 2007 | 9 | 0.570 |
Why?
|
United States | 89 | 2017 | 72334 | 0.570 |
Why?
|
Patient Care Team | 12 | 2017 | 2521 | 0.570 |
Why?
|
Cost Savings | 9 | 2017 | 913 | 0.550 |
Why?
|
Professional-Patient Relations | 2 | 2014 | 726 | 0.550 |
Why?
|
Female | 208 | 2020 | 392644 | 0.540 |
Why?
|
Graves Ophthalmopathy | 2 | 2010 | 133 | 0.540 |
Why?
|
Decision Support Techniques | 12 | 2016 | 1998 | 0.540 |
Why?
|
Protein Conformation | 23 | 2010 | 3968 | 0.530 |
Why?
|
Societies, Medical | 13 | 2016 | 3905 | 0.530 |
Why?
|
Hospital Costs | 7 | 2017 | 947 | 0.530 |
Why?
|
Dexmedetomidine | 2 | 2011 | 319 | 0.530 |
Why?
|
Bacterial Outer Membrane Proteins | 2 | 2010 | 406 | 0.530 |
Why?
|
Death | 3 | 2011 | 676 | 0.530 |
Why?
|
Isoxazoles | 8 | 2007 | 232 | 0.530 |
Why?
|
Railroads | 13 | 2008 | 63 | 0.530 |
Why?
|
Male | 203 | 2020 | 360804 | 0.520 |
Why?
|
Organic Chemicals | 5 | 2008 | 210 | 0.520 |
Why?
|
Guanosine Triphosphate | 10 | 2009 | 316 | 0.520 |
Why?
|
Injections, Spinal | 3 | 2005 | 318 | 0.510 |
Why?
|
Industry | 9 | 2012 | 364 | 0.510 |
Why?
|
Magnesium Oxide | 2 | 2015 | 11 | 0.510 |
Why?
|
Isoenzymes | 10 | 2006 | 1687 | 0.510 |
Why?
|
Air Pollutants | 16 | 2016 | 2896 | 0.500 |
Why?
|
Nebulizers and Vaporizers | 2 | 2009 | 139 | 0.500 |
Why?
|
Fuel Oils | 8 | 2005 | 35 | 0.500 |
Why?
|
Cyanobacteria | 2 | 2006 | 52 | 0.490 |
Why?
|
Environmental Exposure | 27 | 2013 | 4486 | 0.490 |
Why?
|
Hematologic Agents | 1 | 2015 | 40 | 0.490 |
Why?
|
Advance Directives | 4 | 2010 | 249 | 0.490 |
Why?
|
Etoposide | 1 | 2016 | 634 | 0.490 |
Why?
|
Dust | 11 | 2013 | 487 | 0.490 |
Why?
|
Joint Diseases | 5 | 2009 | 459 | 0.480 |
Why?
|
Decision Making | 9 | 2015 | 3929 | 0.480 |
Why?
|
Comprehensive Health Care | 1 | 2015 | 123 | 0.480 |
Why?
|
Insurance, Pharmaceutical Services | 2 | 2015 | 348 | 0.470 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 2 | 2020 | 170 | 0.460 |
Why?
|
Neutropenia | 4 | 2007 | 885 | 0.460 |
Why?
|
Ustilago | 4 | 2001 | 6 | 0.460 |
Why?
|
Quality of Health Care | 11 | 2017 | 4330 | 0.460 |
Why?
|
Cytochrome P-450 Enzyme System | 9 | 2000 | 412 | 0.460 |
Why?
|
Microsomes | 10 | 2001 | 251 | 0.460 |
Why?
|
Euthanasia, Passive | 2 | 2011 | 64 | 0.460 |
Why?
|
N-Acetylmuramoyl-L-alanine Amidase | 4 | 2000 | 50 | 0.450 |
Why?
|
Binding Sites | 18 | 2010 | 6055 | 0.450 |
Why?
|
Calcium Channel Blockers | 4 | 2004 | 694 | 0.450 |
Why?
|
Butadienes | 6 | 2007 | 107 | 0.450 |
Why?
|
Crystallography, X-Ray | 16 | 2010 | 1990 | 0.440 |
Why?
|
Adult | 141 | 2020 | 221177 | 0.440 |
Why?
|
Neutralization Tests | 13 | 2014 | 728 | 0.440 |
Why?
|
Neuralgia, Postherpetic | 1 | 2013 | 41 | 0.430 |
Why?
|
Colorectal Neoplasms | 10 | 2015 | 6935 | 0.430 |
Why?
|
Outpatient Clinics, Hospital | 2 | 2012 | 395 | 0.430 |
Why?
|
Thoracic Neoplasms | 2 | 2008 | 267 | 0.430 |
Why?
|
Orbit | 5 | 1999 | 457 | 0.430 |
Why?
|
Gas Chromatography-Mass Spectrometry | 4 | 2008 | 353 | 0.420 |
Why?
|
Nausea | 3 | 2014 | 679 | 0.420 |
Why?
|
Fentanyl | 2 | 2009 | 434 | 0.420 |
Why?
|
Bromovirus | 2 | 2004 | 4 | 0.420 |
Why?
|
Hospitals, University | 2 | 2012 | 563 | 0.420 |
Why?
|
Patient Selection | 5 | 2017 | 4244 | 0.420 |
Why?
|
Consumer Health Information | 1 | 2015 | 215 | 0.410 |
Why?
|
Graves Disease | 5 | 2010 | 238 | 0.410 |
Why?
|
Morals | 1 | 2015 | 289 | 0.410 |
Why?
|
Religion and Medicine | 1 | 2014 | 161 | 0.410 |
Why?
|
Microsomes, Liver | 10 | 1997 | 173 | 0.410 |
Why?
|
Receptors, Colony-Stimulating Factor | 1 | 2012 | 50 | 0.400 |
Why?
|
Models, Theoretical | 6 | 2015 | 3575 | 0.400 |
Why?
|
Skin Absorption | 6 | 2006 | 94 | 0.400 |
Why?
|
Cucumovirus | 2 | 2002 | 3 | 0.400 |
Why?
|
Partnership Practice | 1 | 2011 | 14 | 0.400 |
Why?
|
Automobiles | 11 | 2001 | 111 | 0.400 |
Why?
|
Solvents | 10 | 2012 | 295 | 0.400 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2009 | 846 | 0.400 |
Why?
|
Epoxy Compounds | 3 | 2007 | 137 | 0.400 |
Why?
|
Aged | 94 | 2017 | 169289 | 0.390 |
Why?
|
Clinical Trials, Phase I as Topic | 2 | 2014 | 326 | 0.390 |
Why?
|
Cryoelectron Microscopy | 6 | 2010 | 650 | 0.390 |
Why?
|
Molecular Sequence Data | 28 | 2014 | 17635 | 0.380 |
Why?
|
Finasteride | 1 | 2012 | 86 | 0.380 |
Why?
|
Zinc | 2 | 2007 | 690 | 0.380 |
Why?
|
Survival Analysis | 21 | 2012 | 10090 | 0.370 |
Why?
|
Particle Size | 20 | 2017 | 1648 | 0.370 |
Why?
|
Tissue and Organ Procurement | 2 | 2011 | 961 | 0.370 |
Why?
|
Bacillus subtilis | 4 | 2000 | 351 | 0.370 |
Why?
|
Amino Acid Sequence | 25 | 2014 | 13446 | 0.370 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 2012 | 112 | 0.370 |
Why?
|
Drugs, Essential | 1 | 2011 | 72 | 0.370 |
Why?
|
Epoprostenol | 1 | 2012 | 247 | 0.370 |
Why?
|
Counseling | 3 | 2010 | 1547 | 0.370 |
Why?
|
Chemotherapy, Adjuvant | 15 | 2016 | 3514 | 0.360 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 20 | 2016 | 11742 | 0.360 |
Why?
|
Arsenic | 9 | 2007 | 362 | 0.360 |
Why?
|
Life Support Care | 2 | 2009 | 226 | 0.360 |
Why?
|
Defensins | 2 | 2007 | 35 | 0.360 |
Why?
|
Hemorrhagic Disease Virus, Rabbit | 1 | 2010 | 2 | 0.360 |
Why?
|
Tombusvirus | 2 | 2007 | 7 | 0.360 |
Why?
|
Geriatrics | 1 | 2015 | 388 | 0.350 |
Why?
|
Cat Diseases | 1 | 2010 | 31 | 0.350 |
Why?
|
alpha-Amylases | 1 | 2010 | 39 | 0.350 |
Why?
|
Testicular Neoplasms | 1 | 2016 | 799 | 0.350 |
Why?
|
Academic Medical Centers | 6 | 2017 | 2759 | 0.350 |
Why?
|
Receptors, Virus | 4 | 2010 | 640 | 0.350 |
Why?
|
Program Development | 2 | 2016 | 1297 | 0.340 |
Why?
|
Protein Structure, Tertiary | 10 | 2010 | 3792 | 0.340 |
Why?
|
Osteophyte | 2 | 2009 | 44 | 0.340 |
Why?
|
Transferases | 2 | 1999 | 72 | 0.340 |
Why?
|
Dyspnea | 3 | 2009 | 1347 | 0.340 |
Why?
|
Surgery Department, Hospital | 2 | 2003 | 176 | 0.340 |
Why?
|
Education, Nursing | 1 | 2010 | 80 | 0.340 |
Why?
|
Bone Marrow Transplantation | 7 | 2009 | 2693 | 0.340 |
Why?
|
Brachyura | 1 | 2009 | 18 | 0.330 |
Why?
|
Squalene | 2 | 2000 | 35 | 0.330 |
Why?
|
Tropical Climate | 1 | 2009 | 35 | 0.330 |
Why?
|
Animal Identification Systems | 1 | 2009 | 1 | 0.330 |
Why?
|
Hyaluronic Acid | 5 | 1999 | 483 | 0.330 |
Why?
|
Time Factors | 45 | 2016 | 39967 | 0.330 |
Why?
|
Tonsillar Neoplasms | 1 | 2009 | 50 | 0.330 |
Why?
|
Oncology Service, Hospital | 3 | 2010 | 57 | 0.330 |
Why?
|
Trees | 1 | 2009 | 55 | 0.330 |
Why?
|
Cattle | 13 | 2009 | 3849 | 0.320 |
Why?
|
Glucuronosyltransferase | 2 | 1999 | 132 | 0.320 |
Why?
|
Patient Satisfaction | 6 | 2015 | 3461 | 0.320 |
Why?
|
Glycosyltransferases | 2 | 1999 | 117 | 0.320 |
Why?
|
Cancer Care Facilities | 2 | 2006 | 422 | 0.320 |
Why?
|
Metallurgy | 9 | 2003 | 95 | 0.320 |
Why?
|
Amylose | 1 | 2008 | 3 | 0.320 |
Why?
|
Skin | 5 | 2012 | 4484 | 0.320 |
Why?
|
Air Pollution | 3 | 2012 | 2359 | 0.320 |
Why?
|
Reimbursement Mechanisms | 3 | 2011 | 667 | 0.320 |
Why?
|
Flavonoids | 5 | 2006 | 445 | 0.310 |
Why?
|
Acetates | 2 | 2001 | 321 | 0.310 |
Why?
|
Metals | 6 | 2005 | 719 | 0.310 |
Why?
|
Chemical Industry | 8 | 2006 | 116 | 0.310 |
Why?
|
Sclerosis | 1 | 2009 | 210 | 0.310 |
Why?
|
Hospital Mortality | 7 | 2015 | 5294 | 0.310 |
Why?
|
Binding Sites, Antibody | 3 | 2005 | 337 | 0.310 |
Why?
|
Dinoprostone | 7 | 2001 | 597 | 0.310 |
Why?
|
Nutritional Sciences | 1 | 2009 | 144 | 0.300 |
Why?
|
Prostatic Hyperplasia | 1 | 2012 | 521 | 0.300 |
Why?
|
Economics, Medical | 1 | 2008 | 112 | 0.300 |
Why?
|
Directed Molecular Evolution | 2 | 2006 | 162 | 0.300 |
Why?
|
Picornaviridae Infections | 1 | 2009 | 95 | 0.300 |
Why?
|
Hamartoma | 1 | 2010 | 235 | 0.300 |
Why?
|
Wind | 2 | 2007 | 42 | 0.290 |
Why?
|
Coated Materials, Biocompatible | 2 | 2008 | 312 | 0.290 |
Why?
|
Antineoplastic Agents, Hormonal | 5 | 2007 | 1520 | 0.290 |
Why?
|
Vinblastine | 4 | 2004 | 488 | 0.290 |
Why?
|
Glutathione Transferase | 6 | 2016 | 565 | 0.290 |
Why?
|
Hospitalization | 11 | 2017 | 10723 | 0.290 |
Why?
|
Alloys | 1 | 2008 | 110 | 0.290 |
Why?
|
Ecosystem | 2 | 2009 | 490 | 0.290 |
Why?
|
Menopause | 3 | 2015 | 1646 | 0.290 |
Why?
|
Resuscitation | 1 | 2012 | 673 | 0.290 |
Why?
|
Delivery of Health Care | 4 | 2017 | 5336 | 0.290 |
Why?
|
Treatment Outcome | 36 | 2016 | 64680 | 0.290 |
Why?
|
Ethics, Medical | 3 | 2011 | 783 | 0.290 |
Why?
|
Job Satisfaction | 2 | 2009 | 544 | 0.290 |
Why?
|
Pilot Projects | 11 | 2016 | 8631 | 0.290 |
Why?
|
Sequence Homology, Amino Acid | 10 | 2007 | 2748 | 0.290 |
Why?
|
Continuity of Patient Care | 2 | 2006 | 1069 | 0.290 |
Why?
|
Risk Assessment | 25 | 2016 | 23995 | 0.290 |
Why?
|
Nickel | 1 | 2008 | 128 | 0.290 |
Why?
|
Early Detection of Cancer | 2 | 2013 | 3201 | 0.290 |
Why?
|
Osteochondritis Dissecans | 1 | 2009 | 118 | 0.280 |
Why?
|
Iron-Binding Proteins | 1 | 2007 | 79 | 0.280 |
Why?
|
Plant Roots | 1 | 2007 | 117 | 0.280 |
Why?
|
Leukocytes | 1 | 2015 | 2026 | 0.280 |
Why?
|
Animals | 90 | 2018 | 168459 | 0.280 |
Why?
|
Antineoplastic Agents, Phytogenic | 3 | 1998 | 621 | 0.280 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2008 | 133 | 0.280 |
Why?
|
Cucumis sativus | 1 | 2006 | 7 | 0.280 |
Why?
|
External Fixators | 2 | 2009 | 99 | 0.280 |
Why?
|
Bone Transplantation | 2 | 2009 | 929 | 0.280 |
Why?
|
Protein Structure, Secondary | 4 | 2009 | 1229 | 0.280 |
Why?
|
Hypothermia, Induced | 1 | 2012 | 753 | 0.280 |
Why?
|
Foreign-Body Migration | 1 | 2009 | 219 | 0.280 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2007 | 97 | 0.280 |
Why?
|
Patient Education as Topic | 4 | 2010 | 2319 | 0.280 |
Why?
|
Rural Health | 3 | 2001 | 296 | 0.280 |
Why?
|
Genetic Testing | 3 | 2010 | 3537 | 0.270 |
Why?
|
Ancillary Services, Hospital | 1 | 2006 | 23 | 0.270 |
Why?
|
RNA, Viral | 5 | 2007 | 2846 | 0.270 |
Why?
|
Xenopus Proteins | 2 | 1999 | 434 | 0.270 |
Why?
|
Gastrointestinal Tract | 2 | 2010 | 833 | 0.270 |
Why?
|
Aldehydes | 1 | 2007 | 170 | 0.270 |
Why?
|
Neoplasm Recurrence, Local | 21 | 2012 | 9280 | 0.270 |
Why?
|
Gene Expression Regulation, Enzymologic | 7 | 2005 | 1171 | 0.270 |
Why?
|
Histidine | 1 | 2007 | 308 | 0.270 |
Why?
|
Drugs, Generic | 1 | 2011 | 448 | 0.270 |
Why?
|
Hydrogen Peroxide | 3 | 2008 | 730 | 0.270 |
Why?
|
Hydrogels | 2 | 2008 | 720 | 0.260 |
Why?
|
Nursing Staff, Hospital | 1 | 2009 | 348 | 0.260 |
Why?
|
Photosynthesis | 1 | 2006 | 68 | 0.260 |
Why?
|
Tamoxifen | 4 | 2004 | 965 | 0.260 |
Why?
|
Power Plants | 3 | 2009 | 124 | 0.260 |
Why?
|
Awareness | 1 | 2010 | 648 | 0.260 |
Why?
|
Lymphokines | 2 | 1999 | 927 | 0.260 |
Why?
|
Environment Design | 1 | 2007 | 173 | 0.260 |
Why?
|
Models, Biological | 13 | 2013 | 9469 | 0.260 |
Why?
|
Randomized Controlled Trials as Topic | 8 | 2017 | 10209 | 0.260 |
Why?
|
Clostridium botulinum | 1 | 2005 | 21 | 0.260 |
Why?
|
Intercellular Adhesion Molecule-1 | 4 | 2016 | 1126 | 0.260 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2014 | 1606 | 0.250 |
Why?
|
Mucins | 1 | 2009 | 568 | 0.250 |
Why?
|
Anion Transport Proteins | 1 | 2006 | 141 | 0.250 |
Why?
|
Petroleum | 9 | 2006 | 80 | 0.250 |
Why?
|
Muscular Diseases | 1 | 2010 | 553 | 0.250 |
Why?
|
Fibroblasts | 13 | 2010 | 4141 | 0.250 |
Why?
|
Qualitative Research | 2 | 2015 | 3023 | 0.250 |
Why?
|
Polysaccharides | 2 | 2009 | 1014 | 0.250 |
Why?
|
Efficiency | 1 | 2009 | 476 | 0.250 |
Why?
|
Biomedical Research | 3 | 2016 | 3429 | 0.250 |
Why?
|
Mutagenesis | 2 | 2007 | 1232 | 0.250 |
Why?
|
Magnesium | 1 | 2009 | 804 | 0.250 |
Why?
|
Kinetics | 16 | 2009 | 6374 | 0.250 |
Why?
|
Intestines | 3 | 2009 | 1909 | 0.250 |
Why?
|
Botulinum Toxins, Type A | 2 | 2005 | 237 | 0.250 |
Why?
|
Chromatography, Gas | 2 | 2006 | 151 | 0.240 |
Why?
|
Durapatite | 1 | 2006 | 163 | 0.240 |
Why?
|
Stress, Psychological | 5 | 2015 | 4481 | 0.240 |
Why?
|
Carbon Compounds, Inorganic | 5 | 1995 | 12 | 0.240 |
Why?
|
Silicon Compounds | 5 | 1995 | 16 | 0.240 |
Why?
|
Diagnostic Errors | 1 | 2012 | 1265 | 0.240 |
Why?
|
Enzymes | 4 | 2008 | 257 | 0.240 |
Why?
|
Eye | 2 | 1999 | 712 | 0.240 |
Why?
|
Physicians | 4 | 2015 | 4591 | 0.240 |
Why?
|
Karnofsky Performance Status | 3 | 2014 | 166 | 0.240 |
Why?
|
Population Surveillance | 5 | 2012 | 2598 | 0.240 |
Why?
|
Recombinant Proteins | 13 | 2012 | 6534 | 0.240 |
Why?
|
Carmovirus | 1 | 2004 | 2 | 0.240 |
Why?
|
Infusion Pumps | 1 | 2005 | 163 | 0.240 |
Why?
|
Occupations | 9 | 2012 | 515 | 0.230 |
Why?
|
Foreign Bodies | 1 | 2009 | 402 | 0.230 |
Why?
|
Antibodies, Monoclonal | 11 | 2014 | 9177 | 0.230 |
Why?
|
Prognosis | 18 | 2016 | 29625 | 0.230 |
Why?
|
Mixed Function Oxygenases | 3 | 2002 | 265 | 0.230 |
Why?
|
Calorimetry, Differential Scanning | 3 | 2008 | 100 | 0.230 |
Why?
|
Aged, 80 and over | 30 | 2017 | 58976 | 0.230 |
Why?
|
Mineral Fibers | 3 | 2000 | 26 | 0.230 |
Why?
|
Critical Pathways | 2 | 2014 | 474 | 0.230 |
Why?
|
Hydromorphone | 1 | 2004 | 70 | 0.230 |
Why?
|
Cost of Illness | 4 | 2016 | 1936 | 0.230 |
Why?
|
Religion | 1 | 2007 | 372 | 0.230 |
Why?
|
Forecasting | 3 | 2012 | 2928 | 0.230 |
Why?
|
Rhodococcus | 2 | 2005 | 13 | 0.230 |
Why?
|
Respiration | 5 | 2002 | 1657 | 0.230 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2008 | 592 | 0.230 |
Why?
|
Medication Adherence | 3 | 2011 | 2176 | 0.230 |
Why?
|
Arabidopsis | 1 | 2007 | 465 | 0.230 |
Why?
|
Stomach Neoplasms | 3 | 2011 | 1459 | 0.230 |
Why?
|
Dogs | 7 | 2009 | 3839 | 0.220 |
Why?
|
Mutagenesis, Site-Directed | 7 | 2007 | 1693 | 0.220 |
Why?
|
Resuscitation Orders | 2 | 2015 | 270 | 0.220 |
Why?
|
Dose-Response Relationship, Drug | 14 | 2010 | 10766 | 0.220 |
Why?
|
Cohort Studies | 31 | 2017 | 41487 | 0.220 |
Why?
|
Membrane Proteins | 7 | 2007 | 7856 | 0.220 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2811 | 0.220 |
Why?
|
Rural Health Services | 2 | 1999 | 384 | 0.220 |
Why?
|
Culture | 1 | 2007 | 623 | 0.220 |
Why?
|
Oxadiazoles | 1 | 2003 | 94 | 0.220 |
Why?
|
Calcium Channels, L-Type | 2 | 2002 | 242 | 0.220 |
Why?
|
Respiratory Tract Fistula | 1 | 2003 | 25 | 0.220 |
Why?
|
Plants, Medicinal | 3 | 2001 | 165 | 0.220 |
Why?
|
Pyrazoles | 1 | 2014 | 2009 | 0.220 |
Why?
|
Methylococcus capsulatus | 4 | 2004 | 8 | 0.220 |
Why?
|
Allyl Compounds | 2 | 2001 | 22 | 0.220 |
Why?
|
Liver | 9 | 2007 | 7529 | 0.220 |
Why?
|
Aphids | 1 | 2002 | 6 | 0.220 |
Why?
|
Drug Prescriptions | 1 | 2012 | 1670 | 0.210 |
Why?
|
Garlic | 2 | 2001 | 28 | 0.210 |
Why?
|
Antifungal Agents | 4 | 2007 | 752 | 0.210 |
Why?
|
Cutaneous Fistula | 1 | 2003 | 79 | 0.210 |
Why?
|
Protein Binding | 12 | 2010 | 9351 | 0.210 |
Why?
|
Cost Control | 7 | 2011 | 628 | 0.210 |
Why?
|
Neurofibromatosis 1 | 1 | 2008 | 561 | 0.210 |
Why?
|
Family Practice | 1 | 2006 | 512 | 0.210 |
Why?
|
Internet | 1 | 2015 | 3092 | 0.210 |
Why?
|
Industrial Oils | 4 | 1997 | 16 | 0.210 |
Why?
|
Program Evaluation | 6 | 2017 | 2495 | 0.210 |
Why?
|
Evolution, Molecular | 4 | 2008 | 1886 | 0.210 |
Why?
|
Colostomy | 1 | 2003 | 105 | 0.210 |
Why?
|
Immunohistochemistry | 4 | 2014 | 11076 | 0.210 |
Why?
|
Lung | 22 | 2001 | 10000 | 0.210 |
Why?
|
Survival Rate | 20 | 2015 | 12725 | 0.210 |
Why?
|
Professional-Family Relations | 1 | 2007 | 495 | 0.210 |
Why?
|
Insulin | 3 | 2008 | 6596 | 0.210 |
Why?
|
Antibody Affinity | 2 | 2018 | 246 | 0.210 |
Why?
|
Receptors, Interleukin-1 | 2 | 2000 | 262 | 0.210 |
Why?
|
Virus Assembly | 4 | 2006 | 139 | 0.210 |
Why?
|
Clinical Protocols | 2 | 2007 | 1440 | 0.210 |
Why?
|
Picornaviridae | 2 | 1999 | 14 | 0.210 |
Why?
|
Oxidoreductases | 3 | 2010 | 413 | 0.210 |
Why?
|
Morphine | 2 | 2005 | 657 | 0.200 |
Why?
|
X-Ray Diffraction | 13 | 2010 | 421 | 0.200 |
Why?
|
Thyroid Gland | 2 | 1999 | 1168 | 0.200 |
Why?
|
Ethylene Glycols | 2 | 2000 | 190 | 0.200 |
Why?
|
Enzyme Activation | 8 | 2009 | 3597 | 0.200 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2016 | 4016 | 0.200 |
Why?
|
Carrier Proteins | 2 | 2007 | 4936 | 0.200 |
Why?
|
Intracranial Hemorrhages | 1 | 2008 | 822 | 0.200 |
Why?
|
Health Expenditures | 2 | 2015 | 2366 | 0.200 |
Why?
|
Pharyngeal Diseases | 1 | 2003 | 134 | 0.200 |
Why?
|
Carcinoma, Small Cell | 2 | 2003 | 420 | 0.200 |
Why?
|
Malaria, Falciparum | 2 | 2010 | 1077 | 0.200 |
Why?
|
Molecular Structure | 7 | 2007 | 1880 | 0.200 |
Why?
|
Pyridines | 2 | 2014 | 2875 | 0.200 |
Why?
|
Human Experimentation | 1 | 2003 | 123 | 0.200 |
Why?
|
Interleukin-1 | 4 | 1999 | 1248 | 0.200 |
Why?
|
Polyethylene Glycols | 4 | 2012 | 1189 | 0.200 |
Why?
|
Patient Preference | 1 | 2009 | 924 | 0.200 |
Why?
|
Scientific Misconduct | 1 | 2003 | 74 | 0.200 |
Why?
|
Costs and Cost Analysis | 5 | 2017 | 1668 | 0.200 |
Why?
|
Biotransformation | 5 | 2007 | 166 | 0.200 |
Why?
|
Heart Arrest | 1 | 2012 | 1514 | 0.200 |
Why?
|
Interprofessional Relations | 1 | 2008 | 990 | 0.200 |
Why?
|
Sulfides | 2 | 2001 | 169 | 0.200 |
Why?
|
Glioblastoma | 1 | 2017 | 3482 | 0.200 |
Why?
|
Mutagens | 4 | 2001 | 179 | 0.200 |
Why?
|
Hematologic Neoplasms | 1 | 2014 | 1896 | 0.200 |
Why?
|
Models, Statistical | 7 | 2010 | 5079 | 0.200 |
Why?
|
Follow-Up Studies | 27 | 2012 | 39106 | 0.190 |
Why?
|
Microscopy, Electron | 10 | 2007 | 2561 | 0.190 |
Why?
|
Oxazoles | 3 | 2003 | 199 | 0.190 |
Why?
|
Tea | 5 | 2006 | 288 | 0.190 |
Why?
|
Thoracoscopy | 1 | 2002 | 181 | 0.190 |
Why?
|
Prostheses and Implants | 2 | 2005 | 1271 | 0.190 |
Why?
|
Laryngectomy | 1 | 2003 | 243 | 0.190 |
Why?
|
Perception | 3 | 2013 | 1197 | 0.190 |
Why?
|
Biomedical Engineering | 1 | 2003 | 288 | 0.190 |
Why?
|
Vitreous Body | 3 | 2003 | 399 | 0.190 |
Why?
|
Office Visits | 1 | 2005 | 595 | 0.190 |
Why?
|
Cause of Death | 11 | 2010 | 3683 | 0.180 |
Why?
|
Students | 2 | 2009 | 1741 | 0.180 |
Why?
|
Indoles | 1 | 2009 | 1833 | 0.180 |
Why?
|
Spinal Cord Injuries | 1 | 2009 | 925 | 0.180 |
Why?
|
Formaldehyde | 4 | 2005 | 358 | 0.180 |
Why?
|
Hypertension, Pulmonary | 1 | 2012 | 1578 | 0.180 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2014 | 942 | 0.180 |
Why?
|
Melanoma | 8 | 2001 | 5709 | 0.180 |
Why?
|
Neoplasm Staging | 20 | 2017 | 11121 | 0.180 |
Why?
|
Plasmodium falciparum | 2 | 2010 | 1742 | 0.180 |
Why?
|
Biotechnology | 1 | 2003 | 282 | 0.180 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2011 | 1469 | 0.180 |
Why?
|
Polymorphism, Genetic | 8 | 2008 | 4243 | 0.180 |
Why?
|
Dietary Supplements | 2 | 2015 | 3415 | 0.180 |
Why?
|
Vanadium | 4 | 2005 | 54 | 0.180 |
Why?
|
Keratitis, Herpetic | 2 | 2000 | 77 | 0.180 |
Why?
|
Analgesia | 1 | 2005 | 461 | 0.180 |
Why?
|
Amino Acid Substitution | 6 | 2007 | 1738 | 0.180 |
Why?
|
Biocompatible Materials | 1 | 2008 | 1685 | 0.180 |
Why?
|
Spectrophotometry, Infrared | 1 | 2000 | 117 | 0.180 |
Why?
|
DNA | 4 | 2010 | 7212 | 0.180 |
Why?
|
Thiocyanates | 5 | 1993 | 70 | 0.180 |
Why?
|
Oxygen | 5 | 2008 | 4227 | 0.180 |
Why?
|
Catechin | 4 | 2008 | 69 | 0.180 |
Why?
|
Personal Autonomy | 3 | 2015 | 304 | 0.170 |
Why?
|
Poverty | 3 | 2013 | 2698 | 0.170 |
Why?
|
Blepharitis | 1 | 2000 | 35 | 0.170 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 3 | 2008 | 161 | 0.170 |
Why?
|
Leukocytes, Mononuclear | 1 | 2007 | 1844 | 0.170 |
Why?
|
Respiration Disorders | 9 | 1997 | 367 | 0.170 |
Why?
|
Liver Cirrhosis | 1 | 2010 | 1935 | 0.170 |
Why?
|
Protein Subunits | 5 | 2004 | 943 | 0.170 |
Why?
|
Aerosols | 11 | 2007 | 635 | 0.170 |
Why?
|
Combined Modality Therapy | 20 | 2012 | 8529 | 0.170 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 1998 | 1374 | 0.170 |
Why?
|
Leukemia, Myelomonocytic, Acute | 1 | 1999 | 38 | 0.170 |
Why?
|
Minerals | 1 | 2001 | 283 | 0.170 |
Why?
|
Disease-Free Survival | 11 | 2012 | 6814 | 0.170 |
Why?
|
Sensitivity and Specificity | 17 | 2012 | 14666 | 0.170 |
Why?
|
Viruses | 2 | 2003 | 375 | 0.170 |
Why?
|
Cataract Extraction | 4 | 2003 | 467 | 0.170 |
Why?
|
Fatal Outcome | 3 | 2009 | 1834 | 0.170 |
Why?
|
Government Programs | 1 | 2001 | 279 | 0.170 |
Why?
|
Temperature | 5 | 2012 | 2226 | 0.170 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2012 | 5671 | 0.160 |
Why?
|
Cybernetics | 1 | 1999 | 7 | 0.160 |
Why?
|
Mass Screening | 4 | 2006 | 5428 | 0.160 |
Why?
|
Risk Factors | 31 | 2016 | 74206 | 0.160 |
Why?
|
Antibodies, Bacterial | 1 | 2005 | 1469 | 0.160 |
Why?
|
Ross River virus | 2 | 1995 | 6 | 0.160 |
Why?
|
Carbohydrate Conformation | 2 | 2010 | 206 | 0.160 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2007 | 506 | 0.160 |
Why?
|
Models, Econometric | 5 | 2000 | 216 | 0.160 |
Why?
|
Spores, Bacterial | 2 | 2000 | 113 | 0.160 |
Why?
|
Thyroiditis, Autoimmune | 1 | 1999 | 101 | 0.160 |
Why?
|
Interferon-alpha | 3 | 2000 | 921 | 0.160 |
Why?
|
Learning | 2 | 2007 | 1740 | 0.160 |
Why?
|
Taiwan | 10 | 2010 | 521 | 0.160 |
Why?
|
Smoking | 23 | 2008 | 9053 | 0.160 |
Why?
|
Insurance, Health | 6 | 2014 | 2498 | 0.160 |
Why?
|
Prostatic Neoplasms | 7 | 2014 | 11118 | 0.160 |
Why?
|
Retrospective Studies | 30 | 2017 | 80636 | 0.160 |
Why?
|
Computer Simulation | 5 | 2013 | 6240 | 0.160 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1999 | 891 | 0.160 |
Why?
|
Herpesvirus 2, Human | 1 | 2000 | 191 | 0.160 |
Why?
|
NAD | 6 | 2005 | 614 | 0.160 |
Why?
|
Schools | 1 | 2007 | 1489 | 0.160 |
Why?
|
Antiviral Agents | 8 | 2006 | 3060 | 0.160 |
Why?
|
Brain Neoplasms | 3 | 2017 | 9031 | 0.160 |
Why?
|
Cachexia | 1 | 2020 | 202 | 0.160 |
Why?
|
Intensive Care Units | 4 | 2014 | 3745 | 0.160 |
Why?
|
Quality Improvement | 6 | 2016 | 3801 | 0.150 |
Why?
|
Dimethylnitrosamine | 1 | 1998 | 17 | 0.150 |
Why?
|
Public-Private Sector Partnerships | 2 | 2016 | 122 | 0.150 |
Why?
|
Pemphigus | 1 | 1999 | 107 | 0.150 |
Why?
|
Porphobilinogen Synthase | 2 | 2008 | 27 | 0.150 |
Why?
|
Water | 4 | 2009 | 1411 | 0.150 |
Why?
|
Fever | 1 | 2006 | 1618 | 0.150 |
Why?
|
Palpation | 3 | 2012 | 166 | 0.150 |
Why?
|
Lymph Node Excision | 4 | 2001 | 1271 | 0.150 |
Why?
|
Sindbis Virus | 2 | 1995 | 36 | 0.150 |
Why?
|
Calorimetry | 2 | 2008 | 129 | 0.150 |
Why?
|
Hyperammonemia | 3 | 2006 | 76 | 0.150 |
Why?
|
Ranitidine | 1 | 1997 | 34 | 0.150 |
Why?
|
Insurance, Health, Reimbursement | 2 | 1999 | 385 | 0.150 |
Why?
|
Health Services Accessibility | 3 | 2014 | 5440 | 0.150 |
Why?
|
Tobacco Smoke Pollution | 5 | 2011 | 819 | 0.150 |
Why?
|
Xenobiotics | 1 | 1998 | 70 | 0.150 |
Why?
|
Mastectomy, Segmental | 5 | 2012 | 955 | 0.150 |
Why?
|
Hematology | 2 | 2001 | 243 | 0.150 |
Why?
|
Crystallization | 10 | 2010 | 534 | 0.150 |
Why?
|
Herpesvirus 1, Human | 2 | 2000 | 753 | 0.150 |
Why?
|
Social Support | 1 | 2008 | 2171 | 0.150 |
Why?
|
Community-Institutional Relations | 2 | 1999 | 206 | 0.150 |
Why?
|
Hydroxyacetylaminofluorene | 2 | 1988 | 2 | 0.150 |
Why?
|
2-Acetylaminofluorene | 2 | 1988 | 10 | 0.150 |
Why?
|
Regression Analysis | 18 | 2011 | 6343 | 0.150 |
Why?
|
Purines | 1 | 2001 | 607 | 0.150 |
Why?
|
Rheology | 2 | 2008 | 347 | 0.150 |
Why?
|
Sunburn | 2 | 2010 | 156 | 0.140 |
Why?
|
Wound Healing | 1 | 2008 | 2805 | 0.140 |
Why?
|
Total Quality Management | 1 | 1999 | 265 | 0.140 |
Why?
|
Genetic Fitness | 1 | 2018 | 115 | 0.140 |
Why?
|
Faculty | 1 | 2001 | 384 | 0.140 |
Why?
|
Adenocarcinoma | 3 | 2011 | 6346 | 0.140 |
Why?
|
Biological Evolution | 3 | 2018 | 1071 | 0.140 |
Why?
|
Plant Oils | 1 | 1998 | 198 | 0.140 |
Why?
|
Healthy Worker Effect | 4 | 2012 | 29 | 0.140 |
Why?
|
Oligosaccharides | 2 | 2010 | 406 | 0.140 |
Why?
|
Drug Delivery Systems | 2 | 2005 | 2226 | 0.140 |
Why?
|
Lung Diseases | 3 | 2004 | 1909 | 0.140 |
Why?
|
Cystatins | 2 | 2007 | 55 | 0.140 |
Why?
|
Taxoids | 2 | 2010 | 668 | 0.140 |
Why?
|
Neoplasms, Experimental | 3 | 1995 | 1229 | 0.140 |
Why?
|
Isocyanates | 2 | 2006 | 12 | 0.140 |
Why?
|
Genetic Counseling | 3 | 2010 | 627 | 0.140 |
Why?
|
Dietary Fats, Unsaturated | 1 | 1998 | 224 | 0.140 |
Why?
|
Sarcoma | 2 | 2003 | 1801 | 0.140 |
Why?
|
Water Supply | 8 | 2007 | 204 | 0.140 |
Why?
|
Geographic Information Systems | 3 | 2011 | 281 | 0.140 |
Why?
|
Static Electricity | 3 | 2003 | 261 | 0.140 |
Why?
|
Macromolecular Substances | 5 | 2004 | 1434 | 0.130 |
Why?
|
Histamine H2 Antagonists | 1 | 1997 | 166 | 0.130 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 7879 | 0.130 |
Why?
|
Curriculum | 1 | 2010 | 3743 | 0.130 |
Why?
|
Pyrethrins | 2 | 2013 | 44 | 0.130 |
Why?
|
Anemia, Sickle Cell | 1 | 2005 | 1063 | 0.130 |
Why?
|
Skin Neoplasms | 7 | 2010 | 5821 | 0.130 |
Why?
|
Materials Testing | 3 | 2008 | 863 | 0.130 |
Why?
|
NADP | 3 | 2009 | 227 | 0.130 |
Why?
|
Neuromyelitis Optica | 1 | 2020 | 263 | 0.130 |
Why?
|
Choice Behavior | 2 | 2016 | 824 | 0.130 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2010 | 4026 | 0.130 |
Why?
|
Insect Vectors | 4 | 2007 | 136 | 0.130 |
Why?
|
Protein Biosynthesis | 3 | 1998 | 2113 | 0.130 |
Why?
|
Anterior Chamber | 2 | 2003 | 194 | 0.130 |
Why?
|
Styrenes | 3 | 1990 | 23 | 0.130 |
Why?
|
Histamine | 1 | 1997 | 499 | 0.130 |
Why?
|
Acetyltransferases | 2 | 1988 | 231 | 0.130 |
Why?
|
Stents | 1 | 2008 | 3179 | 0.130 |
Why?
|
Erythema Infectiosum | 1 | 1995 | 15 | 0.130 |
Why?
|
Hydrocarbons | 3 | 2012 | 105 | 0.130 |
Why?
|
Health Services for the Aged | 2 | 2015 | 259 | 0.130 |
Why?
|
Accidents, Occupational | 1 | 1997 | 249 | 0.130 |
Why?
|
Neoplasms, Second Primary | 2 | 2003 | 1052 | 0.130 |
Why?
|
Absorption | 2 | 2013 | 242 | 0.130 |
Why?
|
Pulmonary Fibrosis | 2 | 2001 | 505 | 0.130 |
Why?
|
Ethical Analysis | 1 | 1995 | 41 | 0.130 |
Why?
|
Health Care Surveys | 3 | 2010 | 2426 | 0.130 |
Why?
|
Fluorouracil | 7 | 2009 | 1641 | 0.130 |
Why?
|
Arsenic Poisoning | 2 | 2007 | 55 | 0.130 |
Why?
|
Opioid-Related Disorders | 1 | 2010 | 2164 | 0.130 |
Why?
|
Carbohydrate Sequence | 2 | 2010 | 411 | 0.130 |
Why?
|
Social Justice | 2 | 2001 | 478 | 0.130 |
Why?
|
Ethics, Institutional | 1 | 2015 | 38 | 0.130 |
Why?
|
Water Pollutants, Chemical | 3 | 2006 | 359 | 0.130 |
Why?
|
Weather | 4 | 2012 | 231 | 0.130 |
Why?
|
Bacteriolysis | 1 | 1995 | 50 | 0.120 |
Why?
|
Dermatologic Agents | 1 | 1999 | 313 | 0.120 |
Why?
|
Surface Properties | 2 | 2008 | 1161 | 0.120 |
Why?
|
Air Pollution, Indoor | 4 | 2006 | 901 | 0.120 |
Why?
|
Calcium | 3 | 2007 | 5722 | 0.120 |
Why?
|
Case-Control Studies | 23 | 2010 | 22176 | 0.120 |
Why?
|
Patient Acceptance of Health Care | 2 | 2008 | 3205 | 0.120 |
Why?
|
Leucine | 2 | 2007 | 548 | 0.120 |
Why?
|
Pancytopenia | 2 | 1995 | 102 | 0.120 |
Why?
|
Workplace | 7 | 2010 | 863 | 0.120 |
Why?
|
Rectal Neoplasms | 2 | 2003 | 1157 | 0.120 |
Why?
|
Mast Cells | 3 | 2001 | 1392 | 0.120 |
Why?
|
Oxidation-Reduction | 8 | 2012 | 2231 | 0.120 |
Why?
|
Endothelial Cells | 1 | 2008 | 3548 | 0.120 |
Why?
|
Lenses, Intraocular | 2 | 2003 | 139 | 0.120 |
Why?
|
Sequence Alignment | 5 | 2014 | 2180 | 0.120 |
Why?
|
Ethics, Clinical | 1 | 1995 | 101 | 0.120 |
Why?
|
Diphosphonates | 1 | 2000 | 636 | 0.120 |
Why?
|
Cyclooxygenase 2 | 5 | 1999 | 597 | 0.120 |
Why?
|
Volatilization | 2 | 2007 | 77 | 0.120 |
Why?
|
Antigen-Antibody Reactions | 3 | 2003 | 340 | 0.120 |
Why?
|
Mammography | 6 | 2012 | 2430 | 0.120 |
Why?
|
Eye Proteins | 1 | 1998 | 633 | 0.120 |
Why?
|
Incineration | 2 | 2007 | 21 | 0.120 |
Why?
|
New Jersey | 2 | 2010 | 295 | 0.120 |
Why?
|
Eye Diseases | 5 | 2003 | 653 | 0.120 |
Why?
|
Welding | 2 | 2005 | 89 | 0.120 |
Why?
|
Rabbits | 5 | 2010 | 4772 | 0.120 |
Why?
|
Cell Line | 11 | 2014 | 15601 | 0.120 |
Why?
|
Young Adult | 11 | 2017 | 59243 | 0.120 |
Why?
|
Maximum Allowable Concentration | 4 | 2005 | 63 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 6 | 2010 | 17904 | 0.120 |
Why?
|
Methotrexate | 3 | 1999 | 1719 | 0.120 |
Why?
|
Computer Graphics | 2 | 1999 | 340 | 0.120 |
Why?
|
Informed Consent | 2 | 2000 | 1008 | 0.120 |
Why?
|
Immunoglobulin G | 5 | 2014 | 4544 | 0.120 |
Why?
|
Drug Utilization | 2 | 1999 | 1188 | 0.110 |
Why?
|
RNA, Messenger | 14 | 2001 | 12795 | 0.110 |
Why?
|
HIV Infections | 3 | 2016 | 17351 | 0.110 |
Why?
|
Double-Blind Method | 6 | 2015 | 12341 | 0.110 |
Why?
|
Glutamic Acid | 4 | 2007 | 1176 | 0.110 |
Why?
|
Butanols | 2 | 2012 | 19 | 0.110 |
Why?
|
Time and Motion Studies | 2 | 2009 | 143 | 0.110 |
Why?
|
Tobacco Mosaic Virus | 2 | 2007 | 17 | 0.110 |
Why?
|
Health Services Research | 3 | 1998 | 1812 | 0.110 |
Why?
|
Cells, Immobilized | 2 | 2012 | 35 | 0.110 |
Why?
|
Skin Diseases | 3 | 2007 | 1094 | 0.110 |
Why?
|
Hyperinsulinism | 3 | 2002 | 400 | 0.110 |
Why?
|
Crystallography | 3 | 2004 | 116 | 0.110 |
Why?
|
Decision Trees | 3 | 1999 | 504 | 0.110 |
Why?
|
Integrative Medicine | 1 | 2015 | 87 | 0.110 |
Why?
|
Biopsy, Needle | 1 | 1999 | 1626 | 0.110 |
Why?
|
Food Handling | 4 | 1987 | 154 | 0.110 |
Why?
|
Nasal Mucosa | 3 | 2000 | 416 | 0.110 |
Why?
|
Ozone | 5 | 2005 | 483 | 0.110 |
Why?
|
Homeostasis | 1 | 2004 | 3323 | 0.110 |
Why?
|
Government Agencies | 2 | 2005 | 160 | 0.110 |
Why?
|
Esophageal Neoplasms | 3 | 1998 | 1654 | 0.110 |
Why?
|
Administration, Inhalation | 5 | 2007 | 1157 | 0.110 |
Why?
|
Gene Expression | 5 | 2002 | 7581 | 0.110 |
Why?
|
Neuralgia | 1 | 2020 | 615 | 0.110 |
Why?
|
Caregivers | 2 | 2017 | 2237 | 0.110 |
Why?
|
Research Report | 1 | 2016 | 367 | 0.110 |
Why?
|
Electric Power Supplies | 1 | 1994 | 96 | 0.110 |
Why?
|
Neoplasm Metastasis | 6 | 2010 | 4915 | 0.110 |
Why?
|
Apoenzymes | 2 | 2003 | 17 | 0.110 |
Why?
|
Anticholesteremic Agents | 1 | 2000 | 966 | 0.110 |
Why?
|
Patient Advocacy | 1 | 1995 | 360 | 0.110 |
Why?
|
Oils | 2 | 1997 | 56 | 0.110 |
Why?
|
Safety Management | 1 | 1999 | 760 | 0.110 |
Why?
|
Acetobacter | 1 | 2012 | 6 | 0.110 |
Why?
|
Narcotics | 2 | 2005 | 336 | 0.110 |
Why?
|
Gels | 1 | 2014 | 420 | 0.110 |
Why?
|
Anopheles | 2 | 2007 | 192 | 0.110 |
Why?
|
Arsenicals | 3 | 2006 | 118 | 0.100 |
Why?
|
Zinc Sulfate | 1 | 2012 | 18 | 0.100 |
Why?
|
Organizational Policy | 1 | 2015 | 432 | 0.100 |
Why?
|
Deductibles and Coinsurance | 1 | 2015 | 316 | 0.100 |
Why?
|
Chlorpyrifos | 1 | 2012 | 19 | 0.100 |
Why?
|
Molecular Conformation | 3 | 2006 | 544 | 0.100 |
Why?
|
Terminology as Topic | 2 | 1997 | 1530 | 0.100 |
Why?
|
Clinical Trials as Topic | 5 | 2011 | 8002 | 0.100 |
Why?
|
Seasons | 5 | 2012 | 1520 | 0.100 |
Why?
|
United States Environmental Protection Agency | 1 | 2012 | 139 | 0.100 |
Why?
|
Taste Disorders | 1 | 2012 | 38 | 0.100 |
Why?
|
Analgesia, Epidural | 2 | 2008 | 332 | 0.100 |
Why?
|
Weight Lifting | 1 | 2012 | 130 | 0.100 |
Why?
|
Gene Expression Regulation | 3 | 2008 | 11903 | 0.100 |
Why?
|
Social Behavior | 1 | 1999 | 1135 | 0.100 |
Why?
|
Habits | 1 | 2013 | 147 | 0.100 |
Why?
|
Administration, Topical | 1 | 2014 | 704 | 0.100 |
Why?
|
Methane | 2 | 2010 | 52 | 0.100 |
Why?
|
Lead | 2 | 2008 | 879 | 0.100 |
Why?
|
Quality-Adjusted Life Years | 3 | 2017 | 1722 | 0.100 |
Why?
|
Esophagus | 1 | 1998 | 1033 | 0.100 |
Why?
|
Viral Envelope Proteins | 1 | 1995 | 640 | 0.100 |
Why?
|
Reference Values | 7 | 2007 | 4920 | 0.100 |
Why?
|
Lymph Nodes | 3 | 2001 | 3466 | 0.100 |
Why?
|
Toxicology | 2 | 2005 | 102 | 0.100 |
Why?
|
Cross Reactions | 2 | 2009 | 817 | 0.100 |
Why?
|
Health Status Indicators | 2 | 2009 | 970 | 0.100 |
Why?
|
Doxorubicin | 5 | 2010 | 2224 | 0.100 |
Why?
|
Reproducibility of Results | 9 | 2013 | 20098 | 0.100 |
Why?
|
Cytochrome P-450 CYP2E1 | 2 | 2001 | 35 | 0.100 |
Why?
|
Ketones | 1 | 2012 | 184 | 0.090 |
Why?
|
Epidemiologic Methods | 5 | 2000 | 1336 | 0.090 |
Why?
|
Hodgkin Disease | 2 | 1997 | 1378 | 0.090 |
Why?
|
Cotinine | 2 | 2011 | 206 | 0.090 |
Why?
|
Thoracotomy | 2 | 2008 | 367 | 0.090 |
Why?
|
Epoxy Resins | 2 | 1987 | 12 | 0.090 |
Why?
|
Cimetidine | 1 | 1991 | 76 | 0.090 |
Why?
|
Genes, p53 | 2 | 2004 | 712 | 0.090 |
Why?
|
Body Burden | 3 | 2008 | 158 | 0.090 |
Why?
|
Life Expectancy | 2 | 2014 | 1242 | 0.090 |
Why?
|
Evidence-Based Practice | 1 | 2015 | 495 | 0.090 |
Why?
|
Microscopy, Electron, Transmission | 3 | 2010 | 695 | 0.090 |
Why?
|
Endothelium | 1 | 2013 | 765 | 0.090 |
Why?
|
Enzyme Stability | 2 | 2009 | 219 | 0.090 |
Why?
|
Mutation | 13 | 2014 | 30052 | 0.090 |
Why?
|
Prospective Studies | 17 | 2017 | 54425 | 0.090 |
Why?
|
Cyclooxygenase 1 | 3 | 1999 | 97 | 0.090 |
Why?
|
Creatinine | 2 | 2007 | 1899 | 0.090 |
Why?
|
Enzyme Induction | 3 | 2001 | 452 | 0.090 |
Why?
|
Health Facility Size | 1 | 2010 | 61 | 0.090 |
Why?
|
Species Specificity | 5 | 2009 | 2414 | 0.090 |
Why?
|
Plant Extracts | 2 | 2009 | 498 | 0.090 |
Why?
|
Complementary Therapies | 1 | 2015 | 486 | 0.090 |
Why?
|
Education, Medical, Continuing | 3 | 2009 | 823 | 0.090 |
Why?
|
Naphthalenes | 2 | 2008 | 198 | 0.090 |
Why?
|
Seeds | 2 | 2009 | 122 | 0.090 |
Why?
|
Mice | 26 | 2018 | 81525 | 0.090 |
Why?
|
Registries | 10 | 2010 | 8224 | 0.090 |
Why?
|
Vomiting | 1 | 2014 | 651 | 0.090 |
Why?
|
Education, Nursing, Continuing | 1 | 1991 | 70 | 0.090 |
Why?
|
Insecticides | 1 | 2012 | 191 | 0.090 |
Why?
|
Conflict of Interest | 2 | 2011 | 554 | 0.090 |
Why?
|
Medicare | 7 | 2014 | 6770 | 0.090 |
Why?
|
Cloning, Molecular | 7 | 2007 | 4174 | 0.090 |
Why?
|
Biopsy | 4 | 2007 | 6766 | 0.090 |
Why?
|
Sequence Analysis, DNA | 4 | 2014 | 4740 | 0.090 |
Why?
|
Diazooxonorleucine | 1 | 1990 | 7 | 0.090 |
Why?
|
Receptors, Thyrotropin | 1 | 2010 | 45 | 0.090 |
Why?
|
Aclarubicin | 1 | 1990 | 12 | 0.090 |
Why?
|
Occupational Medicine | 3 | 1987 | 114 | 0.090 |
Why?
|
Acarbose | 1 | 2010 | 10 | 0.090 |
Why?
|
Methylococcus | 1 | 2010 | 1 | 0.090 |
Why?
|
Ribonucleases | 3 | 2000 | 277 | 0.090 |
Why?
|
Cholinesterase Inhibitors | 1 | 2012 | 242 | 0.090 |
Why?
|
Fungal Proteins | 1 | 1994 | 910 | 0.090 |
Why?
|
Pliability | 1 | 2010 | 58 | 0.090 |
Why?
|
Pesticides | 1 | 2013 | 296 | 0.090 |
Why?
|
Papaver | 1 | 2010 | 5 | 0.090 |
Why?
|
Patient Admission | 1 | 1998 | 1367 | 0.090 |
Why?
|
4-Aminobenzoic Acid | 2 | 1988 | 22 | 0.090 |
Why?
|
Dexamethasone | 4 | 1999 | 1948 | 0.090 |
Why?
|
Trimethylsilyl Compounds | 1 | 2009 | 8 | 0.090 |
Why?
|
Diet | 6 | 2013 | 8075 | 0.090 |
Why?
|
Insurance Coverage | 2 | 2014 | 1940 | 0.090 |
Why?
|
Models, Genetic | 2 | 2018 | 3442 | 0.090 |
Why?
|
Benzene Derivatives | 2 | 2001 | 53 | 0.090 |
Why?
|
Antineoplastic Protocols | 1 | 2010 | 48 | 0.090 |
Why?
|
Role Playing | 1 | 2009 | 22 | 0.090 |
Why?
|
Leukemia | 3 | 2006 | 1522 | 0.090 |
Why?
|
Patient Participation | 2 | 2016 | 1444 | 0.090 |
Why?
|
Industrial Microbiology | 1 | 2009 | 7 | 0.090 |
Why?
|
Arbutin | 1 | 2009 | 2 | 0.090 |
Why?
|
Glutathione S-Transferase pi | 2 | 2007 | 99 | 0.090 |
Why?
|
Lymphatic Metastasis | 9 | 2004 | 2915 | 0.090 |
Why?
|
Nurseries, Hospital | 1 | 2009 | 17 | 0.090 |
Why?
|
Ionic Liquids | 1 | 2009 | 11 | 0.090 |
Why?
|
Polymers | 4 | 2006 | 1617 | 0.090 |
Why?
|
Blotting, Northern | 3 | 2000 | 1545 | 0.090 |
Why?
|
Chromatography, High Pressure Liquid | 6 | 2003 | 1541 | 0.090 |
Why?
|
Midwestern United States | 1 | 2009 | 70 | 0.090 |
Why?
|
Penicillium | 1 | 2009 | 22 | 0.090 |
Why?
|
Family Nursing | 1 | 2009 | 20 | 0.090 |
Why?
|
Carboplatin | 1 | 1993 | 794 | 0.090 |
Why?
|
Rats | 14 | 2006 | 23742 | 0.090 |
Why?
|
Administration, Cutaneous | 1 | 2012 | 713 | 0.090 |
Why?
|
Bithionol | 1 | 2009 | 3 | 0.090 |
Why?
|
Hexachlorophene | 1 | 2009 | 5 | 0.090 |
Why?
|
Tetrahymena | 1 | 2009 | 10 | 0.090 |
Why?
|
Base Sequence | 7 | 2005 | 12441 | 0.080 |
Why?
|
Breast | 1 | 1999 | 1967 | 0.080 |
Why?
|
Alkaloids | 1 | 1991 | 192 | 0.080 |
Why?
|
Azo Compounds | 1 | 1990 | 117 | 0.080 |
Why?
|
Electronics | 2 | 2009 | 318 | 0.080 |
Why?
|
Phenanthrenes | 2 | 2008 | 66 | 0.080 |
Why?
|
Olfaction Disorders | 1 | 2012 | 224 | 0.080 |
Why?
|
Adolescent | 17 | 2015 | 88319 | 0.080 |
Why?
|
Antibodies | 2 | 1999 | 2418 | 0.080 |
Why?
|
Myocardial Ischemia | 2 | 2012 | 2113 | 0.080 |
Why?
|
Hydrogen Bonding | 2 | 2009 | 291 | 0.080 |
Why?
|
Epilepsy, Tonic-Clonic | 1 | 1989 | 54 | 0.080 |
Why?
|
Nucleosides | 1 | 2010 | 131 | 0.080 |
Why?
|
Occupational Health | 3 | 2001 | 806 | 0.080 |
Why?
|
Maximum Tolerated Dose | 1 | 2012 | 883 | 0.080 |
Why?
|
Age Distribution | 2 | 2010 | 2880 | 0.080 |
Why?
|
International Cooperation | 2 | 2017 | 1422 | 0.080 |
Why?
|
Postoperative Complications | 4 | 2003 | 15631 | 0.080 |
Why?
|
Bandages, Hydrocolloid | 1 | 2008 | 8 | 0.080 |
Why?
|
Deamino Arginine Vasopressin | 1 | 1989 | 87 | 0.080 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 931 | 0.080 |
Why?
|
Health Services Misuse | 1 | 2011 | 244 | 0.080 |
Why?
|
Epothilones | 1 | 2009 | 42 | 0.080 |
Why?
|
Viscoelastic Substances | 1 | 2008 | 20 | 0.080 |
Why?
|
Bacteroidetes | 1 | 2009 | 84 | 0.080 |
Why?
|
Chromium | 1 | 2010 | 132 | 0.080 |
Why?
|
Catalysis | 6 | 2010 | 774 | 0.080 |
Why?
|
Coke | 2 | 1999 | 21 | 0.080 |
Why?
|
Ciliophora | 1 | 2008 | 9 | 0.080 |
Why?
|
Repetitive Sequences, Amino Acid | 1 | 2009 | 92 | 0.080 |
Why?
|
Cell Wall | 3 | 2001 | 425 | 0.080 |
Why?
|
PC12 Cells | 2 | 2002 | 317 | 0.080 |
Why?
|
Orthopedic Procedures | 2 | 2009 | 1265 | 0.080 |
Why?
|
Nonheme Iron Proteins | 1 | 2008 | 9 | 0.080 |
Why?
|
Adenosine Triphosphate | 3 | 2006 | 1989 | 0.080 |
Why?
|
Needs Assessment | 1 | 2015 | 1139 | 0.080 |
Why?
|
Patient Care | 1 | 2014 | 622 | 0.080 |
Why?
|
Iris Diseases | 1 | 1989 | 37 | 0.080 |
Why?
|
Nicotine | 4 | 2010 | 680 | 0.080 |
Why?
|
Cats | 1 | 2010 | 975 | 0.080 |
Why?
|
Candida | 1 | 2009 | 172 | 0.080 |
Why?
|
Hospital Charges | 1 | 2010 | 350 | 0.080 |
Why?
|
Health Surveys | 3 | 2014 | 4061 | 0.080 |
Why?
|
Trisaccharides | 1 | 2008 | 50 | 0.080 |
Why?
|
Age Factors | 9 | 2010 | 18395 | 0.080 |
Why?
|
Ferrous Compounds | 1 | 2008 | 41 | 0.080 |
Why?
|
Antibodies, Neutralizing | 2 | 2018 | 1943 | 0.080 |
Why?
|
Solubility | 4 | 2007 | 1091 | 0.080 |
Why?
|
Glucans | 1 | 2008 | 68 | 0.080 |
Why?
|
Severity of Illness Index | 5 | 2011 | 15842 | 0.080 |
Why?
|
beta-Cyclodextrins | 1 | 2008 | 70 | 0.080 |
Why?
|
Treatment Failure | 3 | 2010 | 2645 | 0.080 |
Why?
|
Ethers, Cyclic | 1 | 1988 | 32 | 0.080 |
Why?
|
Equipment Design | 3 | 2008 | 3510 | 0.080 |
Why?
|
Carcinoma, Ductal, Breast | 4 | 1999 | 1085 | 0.080 |
Why?
|
Amination | 1 | 2007 | 18 | 0.080 |
Why?
|
Epitope Mapping | 1 | 2009 | 298 | 0.080 |
Why?
|
Nurses | 1 | 1998 | 2478 | 0.080 |
Why?
|
Polyvinyl Chloride | 4 | 1987 | 32 | 0.080 |
Why?
|
Inpatients | 2 | 2017 | 2548 | 0.080 |
Why?
|
Protein Structure, Quaternary | 1 | 2009 | 429 | 0.080 |
Why?
|
Videotape Recording | 1 | 2009 | 337 | 0.080 |
Why?
|
Geography | 2 | 2010 | 656 | 0.080 |
Why?
|
Hospitals, Urban | 1 | 2010 | 500 | 0.080 |
Why?
|
Postural Balance | 1 | 2012 | 622 | 0.080 |
Why?
|
Methylosinus trichosporium | 1 | 2007 | 1 | 0.080 |
Why?
|
Cisplatin | 4 | 2004 | 1651 | 0.080 |
Why?
|
Unemployment | 1 | 2010 | 210 | 0.070 |
Why?
|
Germination | 1 | 2007 | 17 | 0.070 |
Why?
|
Standard of Care | 1 | 2012 | 551 | 0.070 |
Why?
|
Sunlight | 1 | 2010 | 337 | 0.070 |
Why?
|
Lead Poisoning, Nervous System, Adult | 1 | 2007 | 12 | 0.070 |
Why?
|
Glomerular Filtration Rate | 2 | 2007 | 2176 | 0.070 |
Why?
|
Bone Diseases, Developmental | 1 | 2009 | 131 | 0.070 |
Why?
|
Drug Combinations | 1 | 2014 | 2048 | 0.070 |
Why?
|
Respiratory Tract Diseases | 4 | 2005 | 750 | 0.070 |
Why?
|
Antigens, CD34 | 1 | 2010 | 658 | 0.070 |
Why?
|
Cross-Over Studies | 1 | 2014 | 2078 | 0.070 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 2 | 2000 | 244 | 0.070 |
Why?
|
Mosaic Viruses | 1 | 1987 | 10 | 0.070 |
Why?
|
Receptor, IGF Type 1 | 1 | 2010 | 379 | 0.070 |
Why?
|
Interior Design and Furnishings | 1 | 2007 | 34 | 0.070 |
Why?
|
Mutant Proteins | 2 | 2007 | 491 | 0.070 |
Why?
|
Periplasmic Binding Proteins | 1 | 2007 | 34 | 0.070 |
Why?
|
Endomyocardial Fibrosis | 1 | 2007 | 41 | 0.070 |
Why?
|
Chromatography, Affinity | 4 | 2010 | 532 | 0.070 |
Why?
|
Arylamine N-Acetyltransferase | 1 | 1988 | 87 | 0.070 |
Why?
|
Sarcoma, Kaposi | 1 | 1991 | 374 | 0.070 |
Why?
|
Physicians, Family | 1 | 2009 | 350 | 0.070 |
Why?
|
Focus Groups | 2 | 2017 | 1413 | 0.070 |
Why?
|
Longitudinal Studies | 9 | 2013 | 14605 | 0.070 |
Why?
|
Interleukin-6 | 4 | 2016 | 3208 | 0.070 |
Why?
|
Comorbidity | 4 | 2017 | 10508 | 0.070 |
Why?
|
Anus Neoplasms | 1 | 1991 | 329 | 0.070 |
Why?
|
Butylene Glycols | 1 | 2007 | 11 | 0.070 |
Why?
|
Forced Expiratory Volume | 8 | 2001 | 1814 | 0.070 |
Why?
|
Symbiosis | 1 | 2010 | 294 | 0.070 |
Why?
|
Pneumoconiosis | 3 | 1995 | 32 | 0.070 |
Why?
|
Child, Preschool | 12 | 2013 | 42230 | 0.070 |
Why?
|
Glycols | 1 | 2007 | 55 | 0.070 |
Why?
|
Teaching Materials | 1 | 2007 | 84 | 0.070 |
Why?
|
Patient Simulation | 1 | 2009 | 298 | 0.070 |
Why?
|
Epitopes, B-Lymphocyte | 2 | 1999 | 83 | 0.070 |
Why?
|
Models, Chemical | 2 | 2006 | 611 | 0.070 |
Why?
|
Benzene | 2 | 2000 | 106 | 0.070 |
Why?
|
Environmental Health | 1 | 2010 | 290 | 0.070 |
Why?
|
Respiratory System | 3 | 2000 | 563 | 0.070 |
Why?
|
Lipase | 1 | 2009 | 325 | 0.070 |
Why?
|
HLA-DR Antigens | 2 | 2007 | 602 | 0.070 |
Why?
|
Ions | 1 | 2008 | 256 | 0.070 |
Why?
|
RNA Viruses | 2 | 2001 | 111 | 0.070 |
Why?
|
Surgical Procedures, Operative | 1 | 1998 | 1922 | 0.070 |
Why?
|
Plants, Toxic | 4 | 2000 | 71 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 1 | 1999 | 3396 | 0.070 |
Why?
|
Specialization | 2 | 2003 | 778 | 0.070 |
Why?
|
Child Behavior | 1 | 2013 | 847 | 0.070 |
Why?
|
Melioidosis | 1 | 1986 | 11 | 0.070 |
Why?
|
Nails | 2 | 2006 | 296 | 0.070 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 1 | 2007 | 106 | 0.070 |
Why?
|
Lymphoma, Follicular | 1 | 1991 | 457 | 0.070 |
Why?
|
Carcinoma, Transitional Cell | 2 | 2004 | 782 | 0.070 |
Why?
|
Substrate Specificity | 2 | 2004 | 1791 | 0.070 |
Why?
|
Hydroxylation | 4 | 1997 | 137 | 0.070 |
Why?
|
Automobile Driving | 2 | 2009 | 441 | 0.070 |
Why?
|
Cotton Fiber | 1 | 2006 | 25 | 0.070 |
Why?
|
Streptomyces lividans | 1 | 2006 | 2 | 0.070 |
Why?
|
Phenacetin | 1 | 1986 | 14 | 0.070 |
Why?
|
Community Health Services | 2 | 2007 | 656 | 0.070 |
Why?
|
Hyponatremia | 1 | 1989 | 279 | 0.070 |
Why?
|
Colonic Neoplasms | 4 | 2004 | 2538 | 0.070 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 2 | 2007 | 899 | 0.070 |
Why?
|
Monkey Diseases | 1 | 1986 | 71 | 0.070 |
Why?
|
Amino Acid Motifs | 1 | 2009 | 931 | 0.070 |
Why?
|
Trabeculectomy | 1 | 1988 | 174 | 0.070 |
Why?
|
Iodine Radioisotopes | 1 | 2010 | 1031 | 0.070 |
Why?
|
Boronic Acids | 1 | 2010 | 915 | 0.070 |
Why?
|
Areca | 1 | 2006 | 11 | 0.070 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1995 | 1551 | 0.070 |
Why?
|
Radiography | 6 | 2009 | 6965 | 0.070 |
Why?
|
Silicon | 4 | 1989 | 142 | 0.070 |
Why?
|
Talc | 2 | 1987 | 48 | 0.070 |
Why?
|
Transfection | 3 | 2007 | 5774 | 0.070 |
Why?
|
Vindesine | 2 | 1996 | 12 | 0.070 |
Why?
|
HeLa Cells | 4 | 2006 | 3093 | 0.070 |
Why?
|
Torque | 1 | 2006 | 133 | 0.070 |
Why?
|
Heart Rate | 3 | 2002 | 4195 | 0.070 |
Why?
|
Canada | 4 | 2006 | 2122 | 0.070 |
Why?
|
Serotyping | 2 | 2005 | 325 | 0.070 |
Why?
|
Aluminum Oxide | 1 | 2005 | 41 | 0.070 |
Why?
|
Incidence | 4 | 2010 | 21353 | 0.070 |
Why?
|
Syphilis | 1 | 1989 | 243 | 0.070 |
Why?
|
Maternal Exposure | 2 | 2004 | 1067 | 0.070 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2014 | 2199 | 0.070 |
Why?
|
Predictive Value of Tests | 9 | 2016 | 15266 | 0.070 |
Why?
|
Choristoma | 1 | 2007 | 206 | 0.070 |
Why?
|
Muscle, Smooth | 1 | 2010 | 926 | 0.070 |
Why?
|
Insurance Claim Review | 1 | 2010 | 741 | 0.070 |
Why?
|
Receptors, Glucocorticoid | 1 | 1988 | 305 | 0.070 |
Why?
|
Clergy | 1 | 2007 | 79 | 0.070 |
Why?
|
Methylobacterium | 1 | 2005 | 4 | 0.060 |
Why?
|
Helicobacter pylori | 1 | 2009 | 377 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 1999 | 2332 | 0.060 |
Why?
|
Mitomycin | 3 | 2005 | 263 | 0.060 |
Why?
|
Laryngeal Neoplasms | 2 | 2003 | 514 | 0.060 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 306 | 0.060 |
Why?
|
Imidoesters | 1 | 1985 | 2 | 0.060 |
Why?
|
B-Lymphocyte Subsets | 1 | 2007 | 239 | 0.060 |
Why?
|
Lead Poisoning | 1 | 2008 | 322 | 0.060 |
Why?
|
Sulfhydryl Compounds | 2 | 1997 | 301 | 0.060 |
Why?
|
Probability | 3 | 2005 | 2477 | 0.060 |
Why?
|
Bicarbonates | 1 | 2006 | 292 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 1995 | 2825 | 0.060 |
Why?
|
Keratitis | 1 | 1989 | 241 | 0.060 |
Why?
|
Parathyroid Glands | 1 | 2007 | 518 | 0.060 |
Why?
|
E-Selectin | 1 | 2008 | 576 | 0.060 |
Why?
|
Food Contamination | 1 | 2007 | 191 | 0.060 |
Why?
|
Conjunctival Diseases | 1 | 2006 | 110 | 0.060 |
Why?
|
Infant | 10 | 2013 | 36192 | 0.060 |
Why?
|
Cadmium | 1 | 1986 | 214 | 0.060 |
Why?
|
Family Relations | 1 | 2008 | 317 | 0.060 |
Why?
|
Markov Chains | 5 | 1997 | 966 | 0.060 |
Why?
|
Job Description | 2 | 2004 | 59 | 0.060 |
Why?
|
Cross-Sectional Studies | 9 | 2015 | 26125 | 0.060 |
Why?
|
Medication Errors | 1 | 2011 | 783 | 0.060 |
Why?
|
Tanzania | 1 | 2010 | 1387 | 0.060 |
Why?
|
Statistics, Nonparametric | 4 | 2011 | 2850 | 0.060 |
Why?
|
Proportional Hazards Models | 5 | 2012 | 12463 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2000 | 3245 | 0.060 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2008 | 691 | 0.060 |
Why?
|
Cough | 2 | 2007 | 594 | 0.060 |
Why?
|
Palmitoyl Coenzyme A | 1 | 2004 | 7 | 0.060 |
Why?
|
Advisory Committees | 3 | 2016 | 787 | 0.060 |
Why?
|
Allosteric Site | 2 | 2002 | 103 | 0.060 |
Why?
|
Tetrahymena thermophila | 1 | 2004 | 7 | 0.060 |
Why?
|
Clinical Competence | 3 | 2015 | 4792 | 0.060 |
Why?
|
Mass Spectrometry | 4 | 2009 | 2192 | 0.060 |
Why?
|
DNA, Complementary | 4 | 2002 | 1991 | 0.060 |
Why?
|
Macaca | 1 | 1986 | 410 | 0.060 |
Why?
|
Mediastinal Neoplasms | 1 | 2008 | 401 | 0.060 |
Why?
|
Deamination | 1 | 2004 | 25 | 0.060 |
Why?
|
Germany | 1 | 2007 | 875 | 0.060 |
Why?
|
Chromatography, Ion Exchange | 3 | 1994 | 297 | 0.060 |
Why?
|
Cells, Cultured | 7 | 2002 | 18965 | 0.060 |
Why?
|
Stereoisomerism | 3 | 2012 | 614 | 0.060 |
Why?
|
Zirconium | 1 | 2005 | 108 | 0.060 |
Why?
|
Cities | 4 | 2011 | 546 | 0.060 |
Why?
|
Cell Division | 4 | 2001 | 4465 | 0.060 |
Why?
|
Risk | 8 | 2006 | 9610 | 0.060 |
Why?
|
Textiles | 2 | 2001 | 45 | 0.060 |
Why?
|
Vagus Nerve | 1 | 2007 | 458 | 0.060 |
Why?
|
Glycosaminoglycans | 1 | 1988 | 607 | 0.060 |
Why?
|
Nitrates | 1 | 2006 | 263 | 0.060 |
Why?
|
Microfilament Proteins | 1 | 2010 | 1134 | 0.060 |
Why?
|
Salvage Therapy | 3 | 2005 | 1264 | 0.060 |
Why?
|
Acrylamide | 1 | 2005 | 59 | 0.060 |
Why?
|
Social Isolation | 1 | 2008 | 364 | 0.060 |
Why?
|
Pyrazines | 1 | 2010 | 1201 | 0.060 |
Why?
|
Cycloheximide | 2 | 1999 | 343 | 0.060 |
Why?
|
Glucocorticoids | 2 | 1999 | 2161 | 0.060 |
Why?
|
Fungi | 1 | 2007 | 338 | 0.060 |
Why?
|
Michigan | 5 | 1998 | 339 | 0.060 |
Why?
|
Calcium Phosphates | 1 | 2005 | 171 | 0.060 |
Why?
|
Chagas Disease | 1 | 2006 | 167 | 0.060 |
Why?
|
Health Literacy | 1 | 2010 | 444 | 0.060 |
Why?
|
Carcinoma in Situ | 3 | 1996 | 791 | 0.060 |
Why?
|
Analysis of Variance | 8 | 2000 | 6228 | 0.060 |
Why?
|
Silicon Dioxide | 3 | 1995 | 216 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 1997 | 2491 | 0.060 |
Why?
|
Quality Assurance, Health Care | 3 | 2007 | 2169 | 0.060 |
Why?
|
Lacrimal Apparatus | 1 | 2006 | 223 | 0.060 |
Why?
|
Deoxycytidine | 1 | 2009 | 877 | 0.060 |
Why?
|
Interferon-gamma | 1 | 1993 | 3162 | 0.060 |
Why?
|
Atrazine | 1 | 2004 | 9 | 0.060 |
Why?
|
Nasal Cavity | 1 | 2006 | 304 | 0.060 |
Why?
|
Oncorhynchus mykiss | 2 | 2001 | 20 | 0.060 |
Why?
|
Trypanosoma cruzi | 1 | 2006 | 206 | 0.060 |
Why?
|
Aphthovirus | 2 | 2001 | 2 | 0.060 |
Why?
|
Infusions, Parenteral | 1 | 2004 | 397 | 0.060 |
Why?
|
Vocal Cord Paralysis | 1 | 2007 | 272 | 0.060 |
Why?
|
Odds Ratio | 8 | 2010 | 9646 | 0.060 |
Why?
|
Acyltransferases | 1 | 1986 | 305 | 0.060 |
Why?
|
Universities | 1 | 2009 | 993 | 0.060 |
Why?
|
Hydrogen-Ion Concentration | 4 | 2012 | 2496 | 0.060 |
Why?
|
CD40 Ligand | 3 | 2001 | 522 | 0.060 |
Why?
|
Oxidoreductases Acting on CH-NH Group Donors | 1 | 2004 | 61 | 0.060 |
Why?
|
Genome | 2 | 2002 | 1740 | 0.060 |
Why?
|
Ketoglutaric Acids | 2 | 2002 | 76 | 0.060 |
Why?
|
Lidocaine | 1 | 2007 | 538 | 0.060 |
Why?
|
Polyvinyls | 1 | 1985 | 154 | 0.060 |
Why?
|
Bangladesh | 4 | 2007 | 736 | 0.060 |
Why?
|
Multivariate Analysis | 7 | 2017 | 12059 | 0.060 |
Why?
|
Pyrenes | 2 | 2007 | 49 | 0.060 |
Why?
|
Dermatitis | 1 | 2006 | 202 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2002 | 9000 | 0.060 |
Why?
|
Drug Industry | 2 | 2009 | 788 | 0.060 |
Why?
|
Economics, Hospital | 1 | 2006 | 210 | 0.060 |
Why?
|
Mining | 2 | 1995 | 93 | 0.060 |
Why?
|
Plasminogen Activators | 1 | 2004 | 199 | 0.060 |
Why?
|
Professional Role | 1 | 2007 | 314 | 0.060 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2004 | 87 | 0.060 |
Why?
|
Endotoxins | 1 | 2006 | 520 | 0.060 |
Why?
|
Paternal Exposure | 1 | 2004 | 96 | 0.060 |
Why?
|
Tibia | 2 | 2007 | 1070 | 0.060 |
Why?
|
Lipid Peroxidation | 1 | 2004 | 271 | 0.060 |
Why?
|
Clonidine | 1 | 2004 | 169 | 0.060 |
Why?
|
Lectins, C-Type | 1 | 2007 | 585 | 0.060 |
Why?
|
Leukemia, Radiation-Induced | 1 | 2003 | 39 | 0.060 |
Why?
|
Heart Failure | 1 | 2008 | 11669 | 0.060 |
Why?
|
Medical Indigency | 1 | 2003 | 63 | 0.060 |
Why?
|
C-Reactive Protein | 2 | 2016 | 3826 | 0.060 |
Why?
|
Arginine | 2 | 2004 | 934 | 0.060 |
Why?
|
History, 20th Century | 3 | 2010 | 2767 | 0.060 |
Why?
|
Medicine | 2 | 2003 | 942 | 0.060 |
Why?
|
Bone Marrow Cells | 2 | 2010 | 2416 | 0.060 |
Why?
|
Sheep | 1 | 2006 | 1440 | 0.060 |
Why?
|
Floxuridine | 2 | 2002 | 44 | 0.060 |
Why?
|
Mesothelioma | 1 | 1990 | 807 | 0.060 |
Why?
|
Feasibility Studies | 3 | 2014 | 5247 | 0.060 |
Why?
|
Cell Membrane | 2 | 2010 | 3688 | 0.050 |
Why?
|
History, 21st Century | 1 | 2010 | 1567 | 0.050 |
Why?
|
Hemophilia A | 1 | 2007 | 360 | 0.050 |
Why?
|
Metabolic Clearance Rate | 2 | 2001 | 361 | 0.050 |
Why?
|
Herbicides | 1 | 2004 | 105 | 0.050 |
Why?
|
Intraocular Pressure | 2 | 1990 | 1294 | 0.050 |
Why?
|
Alcohol Oxidoreductases | 1 | 2004 | 169 | 0.050 |
Why?
|
Virus Replication | 3 | 2000 | 2435 | 0.050 |
Why?
|
Water Pollution, Chemical | 1 | 2003 | 31 | 0.050 |
Why?
|
Gene Library | 1 | 2006 | 1059 | 0.050 |
Why?
|
Physical Examination | 3 | 2012 | 1255 | 0.050 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2004 | 325 | 0.050 |
Why?
|
Lenses | 1 | 1983 | 42 | 0.050 |
Why?
|
China | 6 | 2007 | 2369 | 0.050 |
Why?
|
Cricetinae | 6 | 1997 | 2423 | 0.050 |
Why?
|
Family Health | 1 | 2008 | 1257 | 0.050 |
Why?
|
Protein Folding | 2 | 2018 | 870 | 0.050 |
Why?
|
Cysts | 1 | 1988 | 681 | 0.050 |
Why?
|
Molecular Weight | 4 | 2004 | 2186 | 0.050 |
Why?
|
Spirituality | 1 | 2008 | 425 | 0.050 |
Why?
|
Housing | 1 | 2008 | 670 | 0.050 |
Why?
|
Titanium | 1 | 2005 | 485 | 0.050 |
Why?
|
Codes of Ethics | 1 | 2003 | 61 | 0.050 |
Why?
|
Ethics | 1 | 2003 | 94 | 0.050 |
Why?
|
Minority Groups | 1 | 2010 | 1203 | 0.050 |
Why?
|
Attitude | 1 | 2008 | 775 | 0.050 |
Why?
|
Lasers | 1 | 2007 | 952 | 0.050 |
Why?
|
United States Dept. of Health and Human Services | 1 | 2003 | 88 | 0.050 |
Why?
|
Synteny | 1 | 2002 | 77 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2013 | 3113 | 0.050 |
Why?
|
Anecdotes as Topic | 1 | 2002 | 56 | 0.050 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2007 | 1334 | 0.050 |
Why?
|
Vero Cells | 2 | 2000 | 482 | 0.050 |
Why?
|
Social Environment | 1 | 2007 | 1020 | 0.050 |
Why?
|
Gene Products, gag | 2 | 1994 | 312 | 0.050 |
Why?
|
Fraud | 1 | 2003 | 66 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 1999 | 4575 | 0.050 |
Why?
|
Escherichia coli Proteins | 1 | 2009 | 1067 | 0.050 |
Why?
|
Receptors, CXCR4 | 1 | 2007 | 727 | 0.050 |
Why?
|
Bronchoscopy | 1 | 2008 | 909 | 0.050 |
Why?
|
Biflavonoids | 1 | 2001 | 10 | 0.050 |
Why?
|
Bronchial Provocation Tests | 1 | 2002 | 216 | 0.050 |
Why?
|
Ultrasonography | 2 | 2010 | 5972 | 0.050 |
Why?
|
Autoimmunity | 1 | 2010 | 1356 | 0.050 |
Why?
|
Interviews as Topic | 1 | 2009 | 2696 | 0.050 |
Why?
|
Employment | 3 | 2012 | 1118 | 0.050 |
Why?
|
Immunophenotyping | 1 | 2007 | 1870 | 0.050 |
Why?
|
Rats, Wistar | 1 | 2006 | 1848 | 0.050 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 4 | 1994 | 1741 | 0.050 |
Why?
|
Axilla | 3 | 2001 | 624 | 0.050 |
Why?
|
Japan | 1 | 2006 | 1378 | 0.050 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2005 | 339 | 0.050 |
Why?
|
Threonine | 1 | 2002 | 271 | 0.050 |
Why?
|
Alanine | 1 | 2004 | 609 | 0.050 |
Why?
|
Arthroscopy | 1 | 2009 | 969 | 0.050 |
Why?
|
Health Behavior | 2 | 2013 | 2643 | 0.050 |
Why?
|
Ethics Committees | 1 | 2001 | 51 | 0.050 |
Why?
|
Lipoxygenase | 2 | 2001 | 72 | 0.050 |
Why?
|
Eyeglasses | 1 | 1983 | 137 | 0.050 |
Why?
|
Anxiety | 1 | 2017 | 4573 | 0.050 |
Why?
|
Child | 11 | 2010 | 80153 | 0.050 |
Why?
|
Lysine | 2 | 2007 | 993 | 0.050 |
Why?
|
Technetium Tc 99m Sulfur Colloid | 1 | 2001 | 63 | 0.050 |
Why?
|
Genes, Insect | 1 | 2002 | 264 | 0.050 |
Why?
|
Carbon Monoxide | 2 | 1997 | 547 | 0.050 |
Why?
|
Health Benefit Plans, Employee | 1 | 2004 | 333 | 0.050 |
Why?
|
Biofilms | 1 | 2006 | 628 | 0.050 |
Why?
|
Plant Diseases | 1 | 2002 | 178 | 0.050 |
Why?
|
Gamma Cameras | 1 | 2001 | 34 | 0.050 |
Why?
|
Efficiency, Organizational | 1 | 2006 | 695 | 0.050 |
Why?
|
Polycyclic Compounds | 2 | 1999 | 29 | 0.050 |
Why?
|
Antimetabolites, Antineoplastic | 3 | 2002 | 646 | 0.050 |
Why?
|
Egtazic Acid | 1 | 2001 | 167 | 0.050 |
Why?
|
Fatty Acids | 1 | 2009 | 1808 | 0.050 |
Why?
|
Radiography, Thoracic | 1 | 2008 | 1302 | 0.050 |
Why?
|
Lens Implantation, Intraocular | 1 | 2003 | 191 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2005 | 2691 | 0.050 |
Why?
|
Physician's Role | 1 | 2008 | 917 | 0.050 |
Why?
|
Sulfoxides | 1 | 2001 | 48 | 0.050 |
Why?
|
Oligomenorrhea | 1 | 2001 | 42 | 0.050 |
Why?
|
Cysteine | 2 | 2004 | 891 | 0.050 |
Why?
|
Laser Therapy | 1 | 1988 | 1092 | 0.050 |
Why?
|
Electromagnetic Fields | 1 | 2003 | 296 | 0.050 |
Why?
|
Cations, Divalent | 1 | 2001 | 168 | 0.050 |
Why?
|
Anesthetics, Local | 2 | 2007 | 997 | 0.050 |
Why?
|
Calcium-Transporting ATPases | 2 | 1991 | 122 | 0.050 |
Why?
|
Methylation | 5 | 2006 | 1084 | 0.050 |
Why?
|
Organizational Affiliation | 2 | 1999 | 34 | 0.050 |
Why?
|
Polymerase Chain Reaction | 3 | 2006 | 6075 | 0.050 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2004 | 2223 | 0.050 |
Why?
|
Perfusion | 1 | 2006 | 1373 | 0.050 |
Why?
|
Clinical Trials, Phase III as Topic | 3 | 2011 | 857 | 0.050 |
Why?
|
Microbial Sensitivity Tests | 3 | 2009 | 1937 | 0.050 |
Why?
|
Sampling Studies | 3 | 1999 | 615 | 0.050 |
Why?
|
Nitrogen Dioxide | 3 | 2009 | 522 | 0.050 |
Why?
|
Logistic Models | 10 | 2015 | 13255 | 0.050 |
Why?
|
Textile Industry | 2 | 2006 | 74 | 0.050 |
Why?
|
Osteotomy | 1 | 2006 | 837 | 0.050 |
Why?
|
Infusions, Intravenous | 4 | 2002 | 2219 | 0.050 |
Why?
|
Prosthesis-Related Infections | 1 | 2006 | 488 | 0.050 |
Why?
|
Graft Occlusion, Vascular | 1 | 2004 | 537 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 2895 | 0.050 |
Why?
|
Nurse's Role | 1 | 2002 | 188 | 0.050 |
Why?
|
Cryopreservation | 3 | 1995 | 728 | 0.050 |
Why?
|
Immunotherapy | 1 | 2016 | 4652 | 0.050 |
Why?
|
Drug Evaluation | 3 | 1991 | 641 | 0.050 |
Why?
|
Biocatalysis | 2 | 2012 | 170 | 0.050 |
Why?
|
Prostaglandin D2 | 1 | 2000 | 108 | 0.050 |
Why?
|
Education, Medical, Undergraduate | 2 | 2003 | 1070 | 0.040 |
Why?
|
Peer Review | 1 | 2003 | 217 | 0.040 |
Why?
|
Industrial Waste | 1 | 2000 | 23 | 0.040 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2007 | 1050 | 0.040 |
Why?
|
Parents | 2 | 2013 | 3563 | 0.040 |
Why?
|
Interinstitutional Relations | 1 | 2001 | 236 | 0.040 |
Why?
|
Thermodynamics | 2 | 1999 | 595 | 0.040 |
Why?
|
Immunization | 2 | 2000 | 1228 | 0.040 |
Why?
|
Cadmium Poisoning | 1 | 1980 | 11 | 0.040 |
Why?
|
Coumarins | 2 | 1997 | 118 | 0.040 |
Why?
|
Research Design | 4 | 2010 | 6180 | 0.040 |
Why?
|
Reproduction | 1 | 2005 | 645 | 0.040 |
Why?
|
Drug Administration Schedule | 6 | 2008 | 4853 | 0.040 |
Why?
|
Obesity, Morbid | 1 | 1991 | 1277 | 0.040 |
Why?
|
Models, Structural | 2 | 1997 | 340 | 0.040 |
Why?
|
Genotype | 6 | 2007 | 12990 | 0.040 |
Why?
|
Resins, Plant | 2 | 1994 | 20 | 0.040 |
Why?
|
Arachidonic Acid | 1 | 2001 | 427 | 0.040 |
Why?
|
Europe | 2 | 1998 | 3422 | 0.040 |
Why?
|
Macaca mulatta | 1 | 1986 | 2329 | 0.040 |
Why?
|
Prostate-Specific Antigen | 2 | 2007 | 2469 | 0.040 |
Why?
|
Neoplasm Invasiveness | 1 | 2008 | 3595 | 0.040 |
Why?
|
Diabetic Nephropathies | 1 | 2007 | 973 | 0.040 |
Why?
|
Human Rights | 1 | 2003 | 309 | 0.040 |
Why?
|
Teaching | 1 | 2007 | 1170 | 0.040 |
Why?
|
Communication Barriers | 1 | 2003 | 413 | 0.040 |
Why?
|
Viral Core Proteins | 2 | 1990 | 161 | 0.040 |
Why?
|
Patients | 1 | 2006 | 907 | 0.040 |
Why?
|
Glycolates | 1 | 1999 | 40 | 0.040 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1999 | 189 | 0.040 |
Why?
|
Gene Deletion | 1 | 2007 | 2665 | 0.040 |
Why?
|
Nitrobenzenes | 1 | 1999 | 66 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2006 | 1341 | 0.040 |
Why?
|
Mice, Inbred Strains | 1 | 2002 | 1762 | 0.040 |
Why?
|
Glucosamine | 1 | 1999 | 128 | 0.040 |
Why?
|
Blotting, Southern | 1 | 2000 | 777 | 0.040 |
Why?
|
Infant, Newborn | 6 | 2009 | 26198 | 0.040 |
Why?
|
Ocular Physiological Phenomena | 1 | 1999 | 67 | 0.040 |
Why?
|
Circular Dichroism | 2 | 2002 | 344 | 0.040 |
Why?
|
Rodentia | 1 | 2001 | 262 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 2006 | 1866 | 0.040 |
Why?
|
Harringtonines | 1 | 1999 | 8 | 0.040 |
Why?
|
Students, Medical | 2 | 2003 | 1936 | 0.040 |
Why?
|
Fetal Development | 1 | 2005 | 769 | 0.040 |
Why?
|
Tritium | 1 | 1999 | 708 | 0.040 |
Why?
|
Death, Sudden, Cardiac | 1 | 2007 | 1555 | 0.040 |
Why?
|
Catheterization, Central Venous | 1 | 2004 | 527 | 0.040 |
Why?
|
Chromosomes | 1 | 2002 | 577 | 0.040 |
Why?
|
Gold | 1 | 2003 | 482 | 0.040 |
Why?
|
Uridine Diphosphate Glucose Dehydrogenase | 1 | 1998 | 8 | 0.040 |
Why?
|
Electrophysiology | 1 | 2002 | 1262 | 0.040 |
Why?
|
Insurance, Medigap | 1 | 1998 | 21 | 0.040 |
Why?
|
Self-Examination | 1 | 1999 | 71 | 0.040 |
Why?
|
Cytokines | 3 | 1998 | 7396 | 0.040 |
Why?
|
Intestinal Mucosa | 2 | 2001 | 3032 | 0.040 |
Why?
|
California | 1 | 2003 | 1429 | 0.040 |
Why?
|
Ligands | 3 | 2001 | 3272 | 0.040 |
Why?
|
T-Lymphocyte Subsets | 1 | 2007 | 1802 | 0.040 |
Why?
|
Protein Engineering | 1 | 2002 | 549 | 0.040 |
Why?
|
Health Promotion | 2 | 2016 | 2214 | 0.040 |
Why?
|
Freeze Etching | 1 | 1998 | 9 | 0.040 |
Why?
|
Streptomyces | 1 | 1999 | 91 | 0.040 |
Why?
|
Saphenous Vein | 1 | 2002 | 516 | 0.040 |
Why?
|
Sialoglycoproteins | 1 | 1999 | 315 | 0.040 |
Why?
|
Iron | 1 | 2007 | 1793 | 0.040 |
Why?
|
Serine | 1 | 2002 | 830 | 0.040 |
Why?
|
Medically Underserved Area | 2 | 1999 | 254 | 0.040 |
Why?
|
Hepatitis C, Chronic | 1 | 2007 | 1032 | 0.040 |
Why?
|
Catalytic Domain | 1 | 2001 | 705 | 0.040 |
Why?
|
Tachycardia, Ventricular | 1 | 2007 | 1304 | 0.040 |
Why?
|
Electron Transport | 3 | 2005 | 210 | 0.040 |
Why?
|
Disease Progression | 5 | 2007 | 13506 | 0.040 |
Why?
|
Insulin-Secreting Cells | 1 | 2006 | 901 | 0.040 |
Why?
|
Adaptation, Physiological | 1 | 2005 | 1301 | 0.040 |
Why?
|
Hyperplasia | 1 | 2002 | 1152 | 0.040 |
Why?
|
Salaries and Fringe Benefits | 1 | 2001 | 257 | 0.040 |
Why?
|
Inflammation | 4 | 2013 | 10773 | 0.040 |
Why?
|
Proteins | 3 | 2007 | 6032 | 0.040 |
Why?
|
Ammonia | 1 | 1999 | 237 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2002 | 535 | 0.040 |
Why?
|
Dermis | 1 | 1999 | 202 | 0.040 |
Why?
|
Structure-Activity Relationship | 7 | 1996 | 3076 | 0.040 |
Why?
|
Alkynes | 2 | 2012 | 320 | 0.040 |
Why?
|
Sulfones | 1 | 2001 | 448 | 0.040 |
Why?
|
Mitoxantrone | 1 | 1998 | 148 | 0.040 |
Why?
|
Sulfur Dioxide | 3 | 1989 | 178 | 0.040 |
Why?
|
Copper | 1 | 2001 | 369 | 0.040 |
Why?
|
Androgen Antagonists | 1 | 2007 | 1410 | 0.040 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 1999 | 299 | 0.040 |
Why?
|
Viral Vaccines | 2 | 2000 | 596 | 0.040 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1999 | 817 | 0.040 |
Why?
|
Operon | 1 | 1999 | 372 | 0.040 |
Why?
|
Tumor Cells, Cultured | 4 | 2001 | 6132 | 0.040 |
Why?
|
Olivopontocerebellar Atrophies | 1 | 1997 | 19 | 0.040 |
Why?
|
Virus Activation | 1 | 2000 | 322 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 2 | 1993 | 678 | 0.040 |
Why?
|
Erythrocebus patas | 1 | 1997 | 1 | 0.040 |
Why?
|
Liver Neoplasms | 3 | 2002 | 4320 | 0.040 |
Why?
|
Asthma | 4 | 2006 | 6234 | 0.040 |
Why?
|
Peptidoglycan | 1 | 2000 | 249 | 0.040 |
Why?
|
Clinical Laboratory Techniques | 1 | 2003 | 746 | 0.040 |
Why?
|
Cell Compartmentation | 2 | 1995 | 384 | 0.040 |
Why?
|
Testis | 1 | 2001 | 794 | 0.040 |
Why?
|
Menstrual Cycle | 1 | 2001 | 539 | 0.040 |
Why?
|
Thiazolidinediones | 1 | 2000 | 461 | 0.040 |
Why?
|
Safety | 1 | 2002 | 1150 | 0.040 |
Why?
|
Hydroxyurea | 1 | 1999 | 284 | 0.040 |
Why?
|
Neuropsychological Tests | 1 | 1990 | 7045 | 0.040 |
Why?
|
Stem Cell Transplantation | 1 | 2006 | 1600 | 0.040 |
Why?
|
Energy Transfer | 1 | 1997 | 108 | 0.040 |
Why?
|
Health Personnel | 1 | 2011 | 3335 | 0.040 |
Why?
|
Pharyngeal Neoplasms | 1 | 1977 | 113 | 0.040 |
Why?
|
Immunoglobulin A | 2 | 2014 | 978 | 0.040 |
Why?
|
Confidentiality | 1 | 2001 | 609 | 0.040 |
Why?
|
Cyclic AMP | 1 | 2001 | 1463 | 0.040 |
Why?
|
Radionuclide Imaging | 1 | 2001 | 1972 | 0.040 |
Why?
|
Infant, Low Birth Weight | 1 | 2002 | 870 | 0.040 |
Why?
|
Virus Latency | 1 | 2000 | 363 | 0.040 |
Why?
|
Epitopes | 2 | 2014 | 2503 | 0.040 |
Why?
|
Ferrets | 1 | 1997 | 177 | 0.040 |
Why?
|
Mesocricetus | 2 | 1988 | 252 | 0.030 |
Why?
|
Capnography | 1 | 1997 | 91 | 0.030 |
Why?
|
Bronchitis | 1 | 1997 | 196 | 0.030 |
Why?
|
Autonomic Nervous System | 1 | 2002 | 703 | 0.030 |
Why?
|
Calcium Signaling | 1 | 2001 | 733 | 0.030 |
Why?
|
Heart Diseases | 2 | 2007 | 2781 | 0.030 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2001 | 732 | 0.030 |
Why?
|
Causality | 2 | 2007 | 1242 | 0.030 |
Why?
|
Protein Stability | 1 | 2018 | 578 | 0.030 |
Why?
|
Neck | 1 | 2001 | 734 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2010 | 4063 | 0.030 |
Why?
|
Radiation-Sensitizing Agents | 1 | 1998 | 350 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2007 | 5869 | 0.030 |
Why?
|
Antigens, CD | 1 | 2007 | 4003 | 0.030 |
Why?
|
Fabaceae | 2 | 2006 | 103 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2009 | 12974 | 0.030 |
Why?
|
Epistasis, Genetic | 1 | 2018 | 352 | 0.030 |
Why?
|
Cytochrome P-450 CYP1A2 | 1 | 1996 | 69 | 0.030 |
Why?
|
Survivors | 3 | 2001 | 2371 | 0.030 |
Why?
|
Utilization Review | 1 | 1998 | 382 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2020 | 1572 | 0.030 |
Why?
|
Models, Cardiovascular | 1 | 2002 | 981 | 0.030 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 857 | 0.030 |
Why?
|
Asbestos | 3 | 1994 | 251 | 0.030 |
Why?
|
Lymphocyte Activation | 1 | 2007 | 5486 | 0.030 |
Why?
|
Allium | 1 | 1995 | 7 | 0.030 |
Why?
|
Exercise | 1 | 2013 | 5890 | 0.030 |
Why?
|
Fruit | 2 | 2006 | 1160 | 0.030 |
Why?
|
Steroids | 1 | 2001 | 929 | 0.030 |
Why?
|
Styrene | 3 | 1990 | 24 | 0.030 |
Why?
|
Linear Models | 2 | 2004 | 5871 | 0.030 |
Why?
|
Value of Life | 1 | 1996 | 98 | 0.030 |
Why?
|
Genetic Variation | 3 | 2007 | 6567 | 0.030 |
Why?
|
Silicosis | 1 | 1995 | 47 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 1982 | 1560 | 0.030 |
Why?
|
Adrenal Medulla | 1 | 1995 | 56 | 0.030 |
Why?
|
Birth Weight | 2 | 2002 | 2103 | 0.030 |
Why?
|
Parvovirus B19, Human | 1 | 1995 | 40 | 0.030 |
Why?
|
Rotation | 1 | 1997 | 517 | 0.030 |
Why?
|
Amino Acids | 1 | 2002 | 1718 | 0.030 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 1997 | 244 | 0.030 |
Why?
|
Cacodylic Acid | 2 | 2006 | 14 | 0.030 |
Why?
|
Microscopy, Immunoelectron | 1 | 1995 | 317 | 0.030 |
Why?
|
DNA Mutational Analysis | 2 | 1995 | 4111 | 0.030 |
Why?
|
Antigens, Neoplasm | 2 | 1992 | 1993 | 0.030 |
Why?
|
Quality Control | 1 | 1998 | 832 | 0.030 |
Why?
|
Trauma Severity Indices | 1 | 1997 | 478 | 0.030 |
Why?
|
Estradiol | 2 | 2001 | 1937 | 0.030 |
Why?
|
Beneficence | 1 | 1995 | 54 | 0.030 |
Why?
|
Hospital-Physician Relations | 1 | 2015 | 17 | 0.030 |
Why?
|
Ethics Committees, Clinical | 1 | 1995 | 56 | 0.030 |
Why?
|
Mutagenicity Tests | 2 | 1992 | 46 | 0.030 |
Why?
|
Morbidity | 2 | 2003 | 1750 | 0.030 |
Why?
|
Anesthesia, Epidural | 1 | 1997 | 233 | 0.030 |
Why?
|
Teniposide | 1 | 1995 | 11 | 0.030 |
Why?
|
Coculture Techniques | 1 | 1999 | 1341 | 0.030 |
Why?
|
Man-Machine Systems | 1 | 1995 | 42 | 0.030 |
Why?
|
Imides | 1 | 1995 | 15 | 0.030 |
Why?
|
Heart Ventricles | 1 | 2007 | 3807 | 0.030 |
Why?
|
Gallium | 1 | 1995 | 28 | 0.030 |
Why?
|
Anesthesia, Obstetrical | 1 | 1997 | 233 | 0.030 |
Why?
|
Genes, Reporter | 1 | 1999 | 1529 | 0.030 |
Why?
|
Transcription, Genetic | 4 | 2007 | 7594 | 0.030 |
Why?
|
Apoptosis | 2 | 2001 | 9486 | 0.030 |
Why?
|
Mice, Inbred BALB C | 3 | 2014 | 6216 | 0.030 |
Why?
|
Models, Psychological | 1 | 1999 | 828 | 0.030 |
Why?
|
Reaction Time | 1 | 2001 | 2082 | 0.030 |
Why?
|
Mineral Oil | 1 | 1994 | 21 | 0.030 |
Why?
|
Microcomputers | 1 | 1995 | 141 | 0.030 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2002 | 1496 | 0.030 |
Why?
|
Software Design | 1 | 1995 | 171 | 0.030 |
Why?
|
Tissue Donors | 1 | 2004 | 2331 | 0.030 |
Why?
|
Statistics as Topic | 2 | 1994 | 2358 | 0.030 |
Why?
|
Surgical Flaps | 1 | 2003 | 1671 | 0.030 |
Why?
|
Specimen Handling | 1 | 1999 | 702 | 0.030 |
Why?
|
Borates | 1 | 1994 | 19 | 0.030 |
Why?
|
Prevalence | 2 | 2010 | 15732 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2003 | 1089 | 0.030 |
Why?
|
Aminoglutethimide | 1 | 1994 | 13 | 0.030 |
Why?
|
Caliciviridae Infections | 1 | 2014 | 29 | 0.030 |
Why?
|
beta-Lactamases | 1 | 1996 | 304 | 0.030 |
Why?
|
Diagnostic Imaging | 2 | 2012 | 3530 | 0.030 |
Why?
|
Patient Rights | 1 | 2015 | 125 | 0.030 |
Why?
|
Genetic Vectors | 2 | 2002 | 3395 | 0.030 |
Why?
|
Least-Squares Analysis | 3 | 2004 | 369 | 0.030 |
Why?
|
Oximetry | 1 | 1997 | 459 | 0.030 |
Why?
|
Trichloroethylene | 1 | 1994 | 13 | 0.030 |
Why?
|
Mosquito Control | 2 | 2007 | 106 | 0.030 |
Why?
|
Cognition Disorders | 1 | 2008 | 3979 | 0.030 |
Why?
|
United States Department of Agriculture | 1 | 2014 | 47 | 0.030 |
Why?
|
Receptors, Estrogen | 2 | 1993 | 2208 | 0.030 |
Why?
|
Baltimore | 1 | 2014 | 231 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2001 | 3087 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2004 | 6310 | 0.030 |
Why?
|
Pancreatic Neoplasms | 2 | 2005 | 5368 | 0.030 |
Why?
|
Triglycerides | 1 | 2002 | 2461 | 0.030 |
Why?
|
Lymphoma, B-Cell | 1 | 2000 | 940 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2018 | 868 | 0.030 |
Why?
|
Carcinogens, Environmental | 3 | 1988 | 72 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2008 | 3204 | 0.030 |
Why?
|
Mexico | 2 | 2008 | 764 | 0.030 |
Why?
|
Phenotype | 2 | 2010 | 16591 | 0.030 |
Why?
|
Ethanolamines | 3 | 2003 | 153 | 0.030 |
Why?
|
Thyroidectomy | 1 | 1999 | 907 | 0.030 |
Why?
|
Thrombosis | 1 | 2007 | 2942 | 0.030 |
Why?
|
Vegetables | 2 | 1997 | 1195 | 0.030 |
Why?
|
Prednisone | 1 | 1998 | 1563 | 0.030 |
Why?
|
Aspirin | 2 | 1997 | 3133 | 0.030 |
Why?
|
Staphylococcal Protein A | 1 | 1993 | 39 | 0.030 |
Why?
|
Delphi Technique | 1 | 2017 | 846 | 0.030 |
Why?
|
RNA, Double-Stranded | 1 | 1994 | 294 | 0.030 |
Why?
|
Vital Capacity | 4 | 2001 | 971 | 0.030 |
Why?
|
Isoquinolines | 1 | 1995 | 352 | 0.030 |
Why?
|
Atmosphere Exposure Chambers | 2 | 1990 | 51 | 0.030 |
Why?
|
Chemokines | 1 | 1997 | 960 | 0.030 |
Why?
|
omega-Chloroacetophenone | 1 | 2012 | 3 | 0.030 |
Why?
|
Genetic Engineering | 1 | 1999 | 933 | 0.030 |
Why?
|
Papain | 1 | 1993 | 65 | 0.030 |
Why?
|
Resource Allocation | 1 | 1995 | 350 | 0.030 |
Why?
|
Patch-Clamp Techniques | 1 | 1995 | 927 | 0.030 |
Why?
|
Benzoflavones | 1 | 1992 | 7 | 0.030 |
Why?
|
Pepsin A | 1 | 1993 | 66 | 0.030 |
Why?
|
Health Resources | 2 | 1997 | 935 | 0.030 |
Why?
|
Metyrapone | 1 | 1992 | 22 | 0.030 |
Why?
|
Chronic Disease | 3 | 2005 | 9318 | 0.030 |
Why?
|
Poliovirus | 2 | 1999 | 106 | 0.030 |
Why?
|
Drugs, Investigational | 1 | 1995 | 212 | 0.030 |
Why?
|
Cholesterol | 1 | 2002 | 2904 | 0.030 |
Why?
|
Hexuronic Acids | 1 | 2012 | 145 | 0.030 |
Why?
|
Glucuronic Acid | 1 | 2012 | 150 | 0.030 |
Why?
|
Postoperative Care | 1 | 1999 | 1468 | 0.030 |
Why?
|
Therapeutics | 1 | 1993 | 113 | 0.030 |
Why?
|
Bacteriophages | 1 | 1996 | 378 | 0.030 |
Why?
|
Hexanes | 1 | 1992 | 6 | 0.030 |
Why?
|
Gases | 3 | 2002 | 204 | 0.030 |
Why?
|
Urine | 2 | 2007 | 362 | 0.030 |
Why?
|
Integrin beta Chains | 1 | 1992 | 115 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2009 | 7407 | 0.030 |
Why?
|
Physical Chromosome Mapping | 2 | 2002 | 183 | 0.030 |
Why?
|
Vimentin | 1 | 1993 | 255 | 0.020 |
Why?
|
Databases, Factual | 3 | 2016 | 7967 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2014 | 1060 | 0.020 |
Why?
|
Electricity | 1 | 1993 | 181 | 0.020 |
Why?
|
Vermont | 3 | 1995 | 81 | 0.020 |
Why?
|
Organizational Objectives | 1 | 2014 | 426 | 0.020 |
Why?
|
Risk Management | 1 | 1995 | 558 | 0.020 |
Why?
|
Down-Regulation | 1 | 1999 | 2919 | 0.020 |
Why?
|
Stochastic Processes | 1 | 2013 | 355 | 0.020 |
Why?
|
Isoelectric Focusing | 2 | 1990 | 150 | 0.020 |
Why?
|
Codon | 2 | 2004 | 601 | 0.020 |
Why?
|
Parvoviridae | 1 | 1991 | 7 | 0.020 |
Why?
|
Kidney Function Tests | 2 | 2007 | 678 | 0.020 |
Why?
|
Calcium Channels | 1 | 1995 | 620 | 0.020 |
Why?
|
Data Collection | 2 | 1998 | 3322 | 0.020 |
Why?
|
Guinea Pigs | 2 | 2006 | 1310 | 0.020 |
Why?
|
Triiodothyronine, Reverse | 1 | 1991 | 22 | 0.020 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 1993 | 280 | 0.020 |
Why?
|
Work | 1 | 2012 | 195 | 0.020 |
Why?
|
Paint | 2 | 1988 | 34 | 0.020 |
Why?
|
Gene Expression Regulation, Bacterial | 2 | 2009 | 1133 | 0.020 |
Why?
|
Rats, Inbred F344 | 3 | 1993 | 826 | 0.020 |
Why?
|
Urban Population | 2 | 2013 | 2036 | 0.020 |
Why?
|
Polarography | 2 | 1987 | 10 | 0.020 |
Why?
|
Dimethylformamide | 2 | 1987 | 20 | 0.020 |
Why?
|
Chitosan | 1 | 2012 | 131 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1992 | 2088 | 0.020 |
Why?
|
Retinoids | 1 | 1991 | 99 | 0.020 |
Why?
|
Withholding Treatment | 1 | 1995 | 617 | 0.020 |
Why?
|
United States Department of Veterans Affairs | 2 | 2008 | 928 | 0.020 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2006 | 3613 | 0.020 |
Why?
|
Research Support as Topic | 1 | 1995 | 697 | 0.020 |
Why?
|
NF-kappa B | 1 | 1999 | 2490 | 0.020 |
Why?
|
Alginates | 1 | 2012 | 248 | 0.020 |
Why?
|
Mammaplasty | 2 | 1999 | 1239 | 0.020 |
Why?
|
Radiation Injuries | 1 | 1998 | 1189 | 0.020 |
Why?
|
Body Surface Area | 1 | 1991 | 197 | 0.020 |
Why?
|
Mandelic Acids | 1 | 1990 | 46 | 0.020 |
Why?
|
Formamides | 1 | 1990 | 21 | 0.020 |
Why?
|
Family Characteristics | 1 | 1996 | 1004 | 0.020 |
Why?
|
Bacteriophage phi X 174 | 1 | 1990 | 20 | 0.020 |
Why?
|
Calmodulin | 1 | 1991 | 218 | 0.020 |
Why?
|
Mengovirus | 1 | 1990 | 3 | 0.020 |
Why?
|
Sister Chromatid Exchange | 1 | 1990 | 60 | 0.020 |
Why?
|
Mice, Inbred DBA | 2 | 2002 | 621 | 0.020 |
Why?
|
Cardiovascular Diseases | 3 | 2016 | 15500 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 2 | 2002 | 221 | 0.020 |
Why?
|
Sialyltransferases | 1 | 1990 | 83 | 0.020 |
Why?
|
Colon | 1 | 1998 | 1792 | 0.020 |
Why?
|
Body Weight | 3 | 2001 | 4618 | 0.020 |
Why?
|
Triazines | 2 | 2006 | 311 | 0.020 |
Why?
|
Membrane Glycoproteins | 2 | 1998 | 3702 | 0.020 |
Why?
|
Cavernous Sinus | 1 | 1991 | 123 | 0.020 |
Why?
|
Mice, Inbred A | 2 | 2002 | 246 | 0.020 |
Why?
|
Health Care Rationing | 1 | 1993 | 437 | 0.020 |
Why?
|
Spiro Compounds | 1 | 1990 | 68 | 0.020 |
Why?
|
Reticulocytes | 1 | 1991 | 289 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 1999 | 1809 | 0.020 |
Why?
|
Confidence Intervals | 1 | 1995 | 2927 | 0.020 |
Why?
|
Esterification | 1 | 2009 | 39 | 0.020 |
Why?
|
Genetics, Population | 2 | 2005 | 937 | 0.020 |
Why?
|
Erythrocyte Membrane | 1 | 1991 | 439 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2007 | 15936 | 0.020 |
Why?
|
Drug Interactions | 2 | 2006 | 1416 | 0.020 |
Why?
|
Mammals | 1 | 1995 | 1132 | 0.020 |
Why?
|
Campylobacter jejuni | 1 | 2009 | 24 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 1997 | 1779 | 0.020 |
Why?
|
Algorithms | 3 | 2008 | 14031 | 0.020 |
Why?
|
Mucopolysaccharidosis I | 1 | 1990 | 52 | 0.020 |
Why?
|
Enzymes, Immobilized | 1 | 2009 | 52 | 0.020 |
Why?
|
Acylation | 1 | 2009 | 96 | 0.020 |
Why?
|
Motion | 1 | 1993 | 779 | 0.020 |
Why?
|
Colonoscopy | 1 | 1998 | 1394 | 0.020 |
Why?
|
Disclosure | 1 | 1995 | 748 | 0.020 |
Why?
|
Hepatic Artery | 2 | 2002 | 232 | 0.020 |
Why?
|
Lameness, Animal | 1 | 2009 | 7 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 3 | 2008 | 20570 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 1998 | 1886 | 0.020 |
Why?
|
Ships | 2 | 1990 | 53 | 0.020 |
Why?
|
Sulfonamides | 1 | 1999 | 1978 | 0.020 |
Why?
|
Ferric Compounds | 2 | 2008 | 378 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 2010 | 645 | 0.020 |
Why?
|
Carcinoma, Lobular | 1 | 1993 | 481 | 0.020 |
Why?
|
Fibronectins | 1 | 1993 | 723 | 0.020 |
Why?
|
DNA, Viral | 3 | 2007 | 2202 | 0.020 |
Why?
|
Genome, Human | 1 | 2002 | 4425 | 0.020 |
Why?
|
Cellulose | 1 | 2009 | 118 | 0.020 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2002 | 578 | 0.020 |
Why?
|
Airway Resistance | 1 | 1990 | 406 | 0.020 |
Why?
|
Beverages | 1 | 1994 | 821 | 0.020 |
Why?
|
Escherichia coli | 4 | 2009 | 4217 | 0.020 |
Why?
|
Medicine, Traditional | 1 | 2009 | 88 | 0.020 |
Why?
|
Kidney Diseases | 1 | 1980 | 2091 | 0.020 |
Why?
|
Abdomen | 2 | 1993 | 1128 | 0.020 |
Why?
|
Up-Regulation | 1 | 1998 | 4124 | 0.020 |
Why?
|
Ceruloplasmin | 1 | 2008 | 56 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 1999 | 2629 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 2014 | 935 | 0.020 |
Why?
|
Muscle Strength | 1 | 2012 | 624 | 0.020 |
Why?
|
Bacteria | 1 | 1999 | 2199 | 0.020 |
Why?
|
Hospitals, Community | 1 | 1991 | 365 | 0.020 |
Why?
|
Filtration | 1 | 2009 | 228 | 0.020 |
Why?
|
Quartz | 2 | 1987 | 23 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 1996 | 1458 | 0.020 |
Why?
|
Injections | 1 | 1991 | 830 | 0.020 |
Why?
|
Mortality | 2 | 2014 | 2901 | 0.020 |
Why?
|
Missouri | 1 | 2008 | 114 | 0.020 |
Why?
|
Rural Population | 1 | 1999 | 2285 | 0.020 |
Why?
|
Blue Cross Blue Shield Insurance Plans | 2 | 1999 | 92 | 0.020 |
Why?
|
Tetraethylammonium Compounds | 1 | 1987 | 31 | 0.020 |
Why?
|
Integrins | 1 | 1992 | 834 | 0.020 |
Why?
|
Bromides | 1 | 1987 | 22 | 0.020 |
Why?
|
Tetraethylammonium | 1 | 1987 | 55 | 0.020 |
Why?
|
Acetyl Coenzyme A | 1 | 1988 | 74 | 0.020 |
Why?
|
Public Health | 2 | 2004 | 2669 | 0.020 |
Why?
|
Leg | 1 | 1993 | 1088 | 0.020 |
Why?
|
Tretinoin | 1 | 1991 | 519 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2017 | 2421 | 0.020 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2007 | 207 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 1999 | 5789 | 0.020 |
Why?
|
Fourier Analysis | 2 | 1999 | 441 | 0.020 |
Why?
|
Spectrum Analysis | 1 | 2010 | 453 | 0.020 |
Why?
|
Mali | 1 | 2007 | 50 | 0.020 |
Why?
|
Antitussive Agents | 1 | 2007 | 18 | 0.020 |
Why?
|
Socioeconomic Factors | 3 | 1996 | 7827 | 0.020 |
Why?
|
Upper Extremity | 1 | 2012 | 657 | 0.020 |
Why?
|
Software | 2 | 2007 | 4434 | 0.020 |
Why?
|
Propensity Score | 1 | 2015 | 1913 | 0.020 |
Why?
|
Mental Disorders | 1 | 2007 | 6845 | 0.020 |
Why?
|
Arsenates | 1 | 2006 | 10 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2000 | 4758 | 0.020 |
Why?
|
Guidelines as Topic | 2 | 2010 | 1386 | 0.020 |
Why?
|
Glycoproteins | 1 | 1995 | 2203 | 0.020 |
Why?
|
Thyroxine | 1 | 1991 | 666 | 0.020 |
Why?
|
Asparagine | 1 | 2007 | 119 | 0.020 |
Why?
|
Spirometry | 2 | 2001 | 929 | 0.020 |
Why?
|
Body Fluid Compartments | 1 | 2007 | 50 | 0.020 |
Why?
|
Labor Unions | 1 | 2006 | 49 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1186 | 0.020 |
Why?
|
Mental Status Schedule | 1 | 2007 | 314 | 0.020 |
Why?
|
Humerus | 1 | 2009 | 272 | 0.020 |
Why?
|
Biomedical Technology | 1 | 2009 | 211 | 0.020 |
Why?
|
Gonadal Steroid Hormones | 1 | 1991 | 702 | 0.020 |
Why?
|
Arsenites | 1 | 2006 | 65 | 0.020 |
Why?
|
Visual Acuity | 2 | 2003 | 2672 | 0.020 |
Why?
|
Population Density | 1 | 2007 | 193 | 0.020 |
Why?
|
p-Aminoazobenzene | 1 | 1986 | 3 | 0.020 |
Why?
|
Smoke | 1 | 1988 | 235 | 0.020 |
Why?
|
Demography | 2 | 1990 | 1648 | 0.020 |
Why?
|
Biomimetic Materials | 1 | 2008 | 172 | 0.020 |
Why?
|
Hospitals | 1 | 2000 | 3882 | 0.020 |
Why?
|
Chemistry | 1 | 1986 | 347 | 0.020 |
Why?
|
Cyanates | 1 | 2006 | 20 | 0.020 |
Why?
|
Hydrostatic Pressure | 1 | 2006 | 98 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 1990 | 647 | 0.020 |
Why?
|
Eating | 1 | 1993 | 1539 | 0.020 |
Why?
|
Chemical Phenomena | 1 | 1986 | 507 | 0.020 |
Why?
|
Fracture Fixation | 1 | 2009 | 366 | 0.020 |
Why?
|
Accidents | 1 | 2007 | 165 | 0.020 |
Why?
|
Spectrum Analysis, Raman | 1 | 2008 | 237 | 0.020 |
Why?
|
Pseudomonas | 1 | 1986 | 124 | 0.020 |
Why?
|
Drug Resistance, Microbial | 1 | 1989 | 825 | 0.020 |
Why?
|
Stilbenes | 1 | 1987 | 155 | 0.020 |
Why?
|
Injections, Epidural | 1 | 2008 | 201 | 0.020 |
Why?
|
Threshold Limit Values | 1 | 2005 | 12 | 0.020 |
Why?
|
ROC Curve | 1 | 1994 | 3579 | 0.020 |
Why?
|
Bone Plates | 1 | 2009 | 466 | 0.020 |
Why?
|
Breath Tests | 1 | 2007 | 299 | 0.020 |
Why?
|
Anesthetics | 1 | 1991 | 523 | 0.020 |
Why?
|
Chromosome Mapping | 2 | 1998 | 4615 | 0.020 |
Why?
|
Patella | 1 | 2007 | 315 | 0.020 |
Why?
|
Muscular Dystrophies | 1 | 1988 | 390 | 0.020 |
Why?
|
Larva | 1 | 2007 | 508 | 0.020 |
Why?
|
Respiratory Protective Devices | 1 | 2005 | 47 | 0.020 |
Why?
|
Actins | 1 | 1993 | 2050 | 0.020 |
Why?
|
Sulfur | 2 | 1997 | 162 | 0.020 |
Why?
|
Ferritins | 1 | 2008 | 598 | 0.020 |
Why?
|
Hematologic Diseases | 1 | 1989 | 496 | 0.020 |
Why?
|
Bone Screws | 1 | 2009 | 532 | 0.020 |
Why?
|
Densitometry | 1 | 1985 | 151 | 0.020 |
Why?
|
Methanol | 1 | 2005 | 92 | 0.020 |
Why?
|
DNA Primers | 2 | 2002 | 2819 | 0.020 |
Why?
|
Paralysis | 1 | 1986 | 250 | 0.020 |
Why?
|
Acclimatization | 1 | 2005 | 113 | 0.020 |
Why?
|
Interleukin-8 | 2 | 1998 | 695 | 0.020 |
Why?
|
Viral Load | 1 | 2014 | 3332 | 0.020 |
Why?
|
Massachusetts | 2 | 2008 | 8830 | 0.020 |
Why?
|
Orchiectomy | 1 | 2007 | 463 | 0.020 |
Why?
|
Tobacco, Smokeless | 1 | 2006 | 133 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2009 | 3769 | 0.020 |
Why?
|
Scorpion Venoms | 1 | 2004 | 29 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4278 | 0.020 |
Why?
|
Neurospora crassa | 1 | 2004 | 27 | 0.010 |
Why?
|
Aspartic Acid | 1 | 2007 | 576 | 0.010 |
Why?
|
Instillation, Drug | 1 | 2004 | 32 | 0.010 |
Why?
|
Metabolic Networks and Pathways | 1 | 2009 | 789 | 0.010 |
Why?
|
Cystatin C | 1 | 2006 | 269 | 0.010 |
Why?
|
Respiratory Function Tests | 5 | 1989 | 1682 | 0.010 |
Why?
|
Genes, Immunoglobulin | 1 | 2005 | 285 | 0.010 |
Why?
|
Transcription Factors | 2 | 2002 | 12128 | 0.010 |
Why?
|
Collagen | 1 | 1993 | 2638 | 0.010 |
Why?
|
Signal Transduction | 2 | 2005 | 23445 | 0.010 |
Why?
|
Coal | 1 | 2004 | 122 | 0.010 |
Why?
|
Urea | 1 | 2006 | 443 | 0.010 |
Why?
|
Primary Prevention | 1 | 2012 | 1186 | 0.010 |
Why?
|
Louisiana | 1 | 2004 | 103 | 0.010 |
Why?
|
Reye Syndrome | 1 | 1983 | 28 | 0.010 |
Why?
|
Immunoglobulin Variable Region | 1 | 2005 | 419 | 0.010 |
Why?
|
CHO Cells | 2 | 1997 | 1387 | 0.010 |
Why?
|
Population Dynamics | 1 | 2006 | 307 | 0.010 |
Why?
|
Procarbazine | 1 | 2004 | 172 | 0.010 |
Why?
|
Genome, Bacterial | 1 | 2009 | 783 | 0.010 |
Why?
|
Peptide Library | 1 | 2005 | 347 | 0.010 |
Why?
|
Glutamine | 1 | 2007 | 577 | 0.010 |
Why?
|
Death Certificates | 1 | 2004 | 167 | 0.010 |
Why?
|
Expert Testimony | 1 | 2006 | 364 | 0.010 |
Why?
|
Tyrosine | 1 | 2008 | 1440 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2005 | 945 | 0.010 |
Why?
|
RNA, Transfer | 1 | 1986 | 292 | 0.010 |
Why?
|
Prolapse | 1 | 2003 | 63 | 0.010 |
Why?
|
Carcinogenicity Tests | 1 | 2003 | 38 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 1997 | 2947 | 0.010 |
Why?
|
Cerebrospinal Fluid | 1 | 1986 | 544 | 0.010 |
Why?
|
Chromatography, Liquid | 1 | 1987 | 983 | 0.010 |
Why?
|
Imidazoles | 1 | 2009 | 1180 | 0.010 |
Why?
|
HIV | 1 | 1990 | 1582 | 0.010 |
Why?
|
Pregnancy | 5 | 2005 | 29874 | 0.010 |
Why?
|
Acetylation | 1 | 1986 | 1055 | 0.010 |
Why?
|
Paclitaxel | 1 | 1991 | 1732 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2000 | 18252 | 0.010 |
Why?
|
Glaucoma, Open-Angle | 1 | 1990 | 738 | 0.010 |
Why?
|
Biological Assay | 2 | 1987 | 626 | 0.010 |
Why?
|
Chromosome Deletion | 1 | 1988 | 1386 | 0.010 |
Why?
|
Immunity, Mucosal | 1 | 2006 | 483 | 0.010 |
Why?
|
Cytarabine | 1 | 1985 | 697 | 0.010 |
Why?
|
Retirement | 1 | 2004 | 198 | 0.010 |
Why?
|
Psychometrics | 1 | 2013 | 3065 | 0.010 |
Why?
|
Acetonitriles | 1 | 2003 | 54 | 0.010 |
Why?
|
Digestion | 1 | 2002 | 53 | 0.010 |
Why?
|
Conjunctiva | 1 | 2006 | 479 | 0.010 |
Why?
|
Electrochemistry | 1 | 2003 | 145 | 0.010 |
Why?
|
Rubber | 1 | 1982 | 46 | 0.010 |
Why?
|
Cyclophosphamide | 2 | 1999 | 2218 | 0.010 |
Why?
|
Peritonitis | 1 | 1985 | 368 | 0.010 |
Why?
|
Mastectomy | 3 | 1999 | 1822 | 0.010 |
Why?
|
Organophosphorus Compounds | 1 | 1984 | 206 | 0.010 |
Why?
|
Medical History Taking | 1 | 2006 | 774 | 0.010 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2002 | 123 | 0.010 |
Why?
|
Chaperonin 10 | 1 | 2002 | 14 | 0.010 |
Why?
|
Radiotherapy | 2 | 2004 | 1499 | 0.010 |
Why?
|
Drosophila melanogaster | 2 | 2002 | 1712 | 0.010 |
Why?
|
Catalase | 1 | 2003 | 218 | 0.010 |
Why?
|
Histocompatibility Testing | 1 | 2004 | 712 | 0.010 |
Why?
|
Equipment Safety | 1 | 2003 | 249 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 1990 | 1881 | 0.010 |
Why?
|
Expressed Sequence Tags | 1 | 2002 | 250 | 0.010 |
Why?
|
Chromosome Inversion | 1 | 2002 | 120 | 0.010 |
Why?
|
Base Composition | 1 | 2002 | 290 | 0.010 |
Why?
|
Plant Proteins | 1 | 2004 | 370 | 0.010 |
Why?
|
Chaperonin 60 | 1 | 2002 | 97 | 0.010 |
Why?
|
Drug Resistance, Viral | 1 | 2007 | 862 | 0.010 |
Why?
|
Osteogenesis | 1 | 2009 | 1273 | 0.010 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2004 | 410 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2003 | 767 | 0.010 |
Why?
|
Immunoassay | 1 | 2005 | 745 | 0.010 |
Why?
|
Drug Monitoring | 1 | 2008 | 962 | 0.010 |
Why?
|
3-Hydroxysteroid Dehydrogenases | 1 | 2001 | 34 | 0.010 |
Why?
|
Cholesterol Side-Chain Cleavage Enzyme | 1 | 2001 | 28 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6484 | 0.010 |
Why?
|
Steroid 11-beta-Hydroxylase | 1 | 2001 | 20 | 0.010 |
Why?
|
Aziridines | 1 | 2001 | 21 | 0.010 |
Why?
|
Vincristine | 1 | 2004 | 1036 | 0.010 |
Why?
|
Insect Proteins | 1 | 2002 | 254 | 0.010 |
Why?
|
Mechlorethamine | 1 | 2001 | 129 | 0.010 |
Why?
|
Health Policy | 1 | 2013 | 2684 | 0.010 |
Why?
|
Steroid Hydroxylases | 1 | 2001 | 93 | 0.010 |
Why?
|
Databases, Nucleic Acid | 1 | 2002 | 205 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2006 | 1784 | 0.010 |
Why?
|
Steroid 17-alpha-Hydroxylase | 1 | 2001 | 99 | 0.010 |
Why?
|
Surface Plasmon Resonance | 1 | 2002 | 269 | 0.010 |
Why?
|
Technology Assessment, Biomedical | 2 | 1994 | 307 | 0.010 |
Why?
|
Calcinosis | 1 | 1989 | 1469 | 0.010 |
Why?
|
Soft Tissue Neoplasms | 1 | 1990 | 1159 | 0.010 |
Why?
|
Vascular Patency | 1 | 2004 | 911 | 0.010 |
Why?
|
Hydrolysis | 1 | 2002 | 664 | 0.010 |
Why?
|
Posture | 1 | 1985 | 957 | 0.010 |
Why?
|
Aromatase | 1 | 2001 | 147 | 0.010 |
Why?
|
Chromans | 1 | 2000 | 117 | 0.010 |
Why?
|
Dinoprost | 1 | 2000 | 138 | 0.010 |
Why?
|
Quality Indicators, Health Care | 1 | 2010 | 1792 | 0.010 |
Why?
|
Syndrome | 2 | 2001 | 3267 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2004 | 666 | 0.010 |
Why?
|
Electrodes | 1 | 2003 | 614 | 0.010 |
Why?
|
Amines | 1 | 2002 | 281 | 0.010 |
Why?
|
Nervous System Diseases | 2 | 1996 | 1666 | 0.010 |
Why?
|
Computational Biology | 2 | 2002 | 3518 | 0.010 |
Why?
|
Chromosomes, Human | 1 | 2002 | 441 | 0.010 |
Why?
|
Sigmoidoscopy | 1 | 2000 | 151 | 0.010 |
Why?
|
Boston | 1 | 2013 | 9326 | 0.010 |
Why?
|
India | 1 | 2007 | 2348 | 0.010 |
Why?
|
Public Policy | 1 | 2004 | 559 | 0.010 |
Why?
|
Blood | 1 | 2002 | 596 | 0.010 |
Why?
|
Exons | 2 | 2001 | 2391 | 0.010 |
Why?
|
Oxidants, Photochemical | 1 | 2000 | 76 | 0.010 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2001 | 266 | 0.010 |
Why?
|
Culture Media | 1 | 2002 | 897 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2003 | 1090 | 0.010 |
Why?
|
Occult Blood | 1 | 2000 | 198 | 0.010 |
Why?
|
Tunica Intima | 1 | 2002 | 459 | 0.010 |
Why?
|
Automation | 1 | 2002 | 586 | 0.010 |
Why?
|
Mastectomy, Simple | 1 | 1999 | 23 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 2000 | 915 | 0.010 |
Why?
|
Nose Diseases | 1 | 2000 | 79 | 0.010 |
Why?
|
Organ Culture Techniques | 1 | 2002 | 794 | 0.010 |
Why?
|
Microscopy, Phase-Contrast | 1 | 1999 | 110 | 0.010 |
Why?
|
Carcinoembryonic Antigen | 1 | 2000 | 337 | 0.010 |
Why?
|
Macrophages | 1 | 2014 | 5769 | 0.010 |
Why?
|
Adaptation, Biological | 1 | 2000 | 147 | 0.010 |
Why?
|
beta 2-Microglobulin | 1 | 1980 | 329 | 0.010 |
Why?
|
Vanadium Compounds | 1 | 1998 | 8 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2002 | 1163 | 0.010 |
Why?
|
Protein Denaturation | 1 | 1999 | 242 | 0.010 |
Why?
|
Eosinophil Granule Proteins | 1 | 1998 | 29 | 0.010 |
Why?
|
Nasal Lavage Fluid | 1 | 1998 | 17 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14414 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 2002 | 755 | 0.010 |
Why?
|
Pharyngitis | 1 | 2000 | 219 | 0.010 |
Why?
|
Hexosaminidases | 1 | 1998 | 45 | 0.010 |
Why?
|
Genes | 1 | 2002 | 1823 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2004 | 3416 | 0.010 |
Why?
|
Transplantation, Autologous | 2 | 1994 | 2115 | 0.010 |
Why?
|
Biophysical Phenomena | 1 | 1999 | 320 | 0.010 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1990 | 2298 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1982 | 1351 | 0.010 |
Why?
|
Reoperation | 1 | 1988 | 4303 | 0.010 |
Why?
|
Receptors, Androgen | 1 | 2004 | 1079 | 0.010 |
Why?
|
Alcohol Drinking | 2 | 2003 | 4028 | 0.010 |
Why?
|
Medical Record Linkage | 1 | 1999 | 285 | 0.010 |
Why?
|
Bone and Bones | 1 | 2008 | 2568 | 0.010 |
Why?
|
Meat-Packing Industry | 2 | 1987 | 12 | 0.010 |
Why?
|
Biophysics | 1 | 1999 | 380 | 0.010 |
Why?
|
Endoscopy | 1 | 2007 | 1851 | 0.010 |
Why?
|
Nitroso Compounds | 1 | 1997 | 71 | 0.010 |
Why?
|
Sputum | 1 | 2000 | 506 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2012 | 4948 | 0.010 |
Why?
|
Malaria | 1 | 2007 | 1227 | 0.010 |
Why?
|
Hemorrhage | 1 | 1989 | 3424 | 0.010 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 1997 | 114 | 0.010 |
Why?
|
Medicaid | 1 | 2010 | 2818 | 0.010 |
Why?
|
Penicillin G | 1 | 1996 | 40 | 0.010 |
Why?
|
Nitrous Oxide | 1 | 1997 | 166 | 0.010 |
Why?
|
Fractures, Bone | 1 | 2009 | 2046 | 0.010 |
Why?
|
Aluminum | 1 | 1997 | 152 | 0.010 |
Why?
|
Colitis | 1 | 1985 | 1233 | 0.010 |
Why?
|
Baculoviridae | 1 | 1996 | 115 | 0.010 |
Why?
|
Calibration | 1 | 1999 | 818 | 0.010 |
Why?
|
Blood Gas Analysis | 1 | 1997 | 379 | 0.010 |
Why?
|
Genes, Fungal | 1 | 1998 | 439 | 0.010 |
Why?
|
Haplotypes | 1 | 2002 | 2713 | 0.010 |
Why?
|
Genetic Markers | 1 | 2002 | 2601 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2007 | 2775 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2000 | 2265 | 0.010 |
Why?
|
Hepatectomy | 1 | 1999 | 557 | 0.010 |
Why?
|
Respiratory Sounds | 1 | 2000 | 702 | 0.010 |
Why?
|
Pressure | 1 | 1999 | 1154 | 0.010 |
Why?
|
Organ Specificity | 1 | 2000 | 1967 | 0.010 |
Why?
|
Cephalosporins | 1 | 1996 | 198 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 2 | 2000 | 8181 | 0.010 |
Why?
|
Naphthalimides | 1 | 1995 | 22 | 0.010 |
Why?
|
Cold Temperature | 1 | 1999 | 785 | 0.010 |
Why?
|
Mutagenesis, Insertional | 1 | 1998 | 656 | 0.010 |
Why?
|
Pharmacogenetics | 1 | 1999 | 675 | 0.010 |
Why?
|
Peroxidase | 1 | 1998 | 609 | 0.010 |
Why?
|
Chlorine | 1 | 1994 | 57 | 0.010 |
Why?
|
Medical Records | 1 | 2000 | 1408 | 0.010 |
Why?
|
Body Mass Index | 1 | 2012 | 12953 | 0.010 |
Why?
|
Fats | 1 | 1994 | 99 | 0.010 |
Why?
|
Isoflurane | 1 | 1997 | 384 | 0.010 |
Why?
|
Random Allocation | 2 | 1990 | 2395 | 0.010 |
Why?
|
SEER Program | 1 | 1999 | 1450 | 0.010 |
Why?
|
Freezing | 1 | 1995 | 311 | 0.010 |
Why?
|
Dietary Fats | 1 | 2002 | 1995 | 0.010 |
Why?
|
T-Lymphocytes | 2 | 2001 | 10194 | 0.010 |
Why?
|
Encephalitis, Japanese | 1 | 1973 | 13 | 0.010 |
Why?
|
Women, Working | 1 | 1994 | 86 | 0.010 |
Why?
|
Antioxidants | 1 | 2001 | 1668 | 0.010 |
Why?
|
Ciprofloxacin | 1 | 1995 | 312 | 0.010 |
Why?
|
Staining and Labeling | 1 | 1998 | 1085 | 0.010 |
Why?
|
Thiazoles | 1 | 2000 | 1517 | 0.010 |
Why?
|
Models, Animal | 1 | 2000 | 2112 | 0.010 |
Why?
|
Technology, High-Cost | 1 | 1993 | 32 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 9420 | 0.010 |
Why?
|
Remission Induction | 1 | 1999 | 2396 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 1997 | 1147 | 0.010 |
Why?
|
Feces | 1 | 2000 | 1497 | 0.010 |
Why?
|
Blood Proteins | 1 | 1998 | 1173 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2000 | 22169 | 0.010 |
Why?
|
Lymphoma | 1 | 1982 | 1901 | 0.010 |
Why?
|
Proteome | 1 | 2002 | 1862 | 0.010 |
Why?
|
Sweden | 1 | 1995 | 1379 | 0.010 |
Why?
|
Anesthetics, Inhalation | 1 | 1997 | 574 | 0.010 |
Why?
|
Cytochrome P-450 CYP2B1 | 1 | 1991 | 21 | 0.010 |
Why?
|
Rhinitis | 1 | 2000 | 747 | 0.010 |
Why?
|
Olfactory Mucosa | 1 | 1992 | 101 | 0.010 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2004 | 2518 | 0.010 |
Why?
|
Thiourea | 1 | 1991 | 68 | 0.010 |
Why?
|
Adrenalectomy | 1 | 1994 | 346 | 0.010 |
Why?
|
Abducens Nerve | 1 | 1991 | 28 | 0.010 |
Why?
|
National Institutes of Health (U.S.) | 1 | 1995 | 793 | 0.010 |
Why?
|
Cell Survival | 1 | 2002 | 5791 | 0.010 |
Why?
|
Cell Lineage | 1 | 2000 | 2555 | 0.010 |
Why?
|
Trochlear Nerve | 1 | 1991 | 26 | 0.010 |
Why?
|
Hypotension | 1 | 1997 | 879 | 0.010 |
Why?
|
Hemagglutinins, Viral | 1 | 1991 | 66 | 0.010 |
Why?
|
Oculomotor Nerve | 1 | 1991 | 72 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1998 | 3810 | 0.010 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 1990 | 221 | 0.010 |
Why?
|
Cranial Nerve Diseases | 1 | 1991 | 113 | 0.010 |
Why?
|
HIV Core Protein p24 | 1 | 1990 | 245 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1992 | 779 | 0.010 |
Why?
|
Obesity | 1 | 2013 | 12947 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2002 | 3188 | 0.010 |
Why?
|
Esthetics | 1 | 1992 | 330 | 0.010 |
Why?
|
Cytoplasm | 1 | 1994 | 1510 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1990 | 851 | 0.010 |
Why?
|
Social Class | 1 | 1999 | 2004 | 0.010 |
Why?
|
Gonioscopy | 1 | 1990 | 155 | 0.010 |
Why?
|
Trigeminal Nerve | 1 | 1991 | 248 | 0.010 |
Why?
|
Liver Neoplasms, Experimental | 1 | 1990 | 189 | 0.010 |
Why?
|
Receptors, Drug | 1 | 1989 | 157 | 0.010 |
Why?
|
Aging | 1 | 2008 | 8708 | 0.010 |
Why?
|
Sex Distribution | 1 | 1994 | 2281 | 0.010 |
Why?
|
Methylene Chloride | 1 | 1988 | 11 | 0.010 |
Why?
|
Internship and Residency | 1 | 1989 | 5880 | 0.010 |
Why?
|
Adenine | 1 | 1995 | 987 | 0.010 |
Why?
|
Mitochondria | 1 | 2002 | 3624 | 0.000 |
Why?
|
Educational Measurement | 1 | 1996 | 1254 | 0.000 |
Why?
|
Sex Factors | 1 | 2002 | 10552 | 0.000 |
Why?
|
Hypoglycemic Agents | 1 | 2000 | 3085 | 0.000 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1998 | 4352 | 0.000 |
Why?
|
Antigens, Viral | 1 | 1991 | 988 | 0.000 |
Why?
|
Meta-Analysis as Topic | 1 | 1992 | 1380 | 0.000 |
Why?
|
Nucleic Acid Hybridization | 1 | 1988 | 1302 | 0.000 |
Why?
|
Genomics | 1 | 2002 | 5821 | 0.000 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1987 | 411 | 0.000 |
Why?
|
Cell Movement | 1 | 1998 | 5203 | 0.000 |
Why?
|
Mathematics | 1 | 1987 | 707 | 0.000 |
Why?
|
Adenoma | 1 | 1996 | 2160 | 0.000 |
Why?
|
Introns | 1 | 1988 | 981 | 0.000 |
Why?
|
Cryptococcosis | 1 | 1985 | 104 | 0.000 |
Why?
|
Saccharomyces cerevisiae | 1 | 1994 | 2688 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2000 | 9606 | 0.000 |
Why?
|
Plasmids | 1 | 1988 | 2269 | 0.000 |
Why?
|
Lymphocytes | 1 | 1990 | 2612 | 0.000 |
Why?
|
Recombinant Fusion Proteins | 1 | 1990 | 3734 | 0.000 |
Why?
|
Blood Pressure | 1 | 1997 | 8481 | 0.000 |
Why?
|
Cell Nucleus | 1 | 1990 | 2909 | 0.000 |
Why?
|
Testosterone | 1 | 1991 | 2472 | 0.000 |
Why?
|
Recurrence | 1 | 1992 | 8465 | 0.000 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 1985 | 1116 | 0.000 |
Why?
|
Culex | 1 | 1973 | 18 | 0.000 |
Why?
|
Encephalitis Virus, Japanese | 1 | 1973 | 12 | 0.000 |
Why?
|
Animals, Domestic | 1 | 1973 | 56 | 0.000 |
Why?
|
Disease Reservoirs | 1 | 1973 | 121 | 0.000 |
Why?
|
Tropical Medicine | 1 | 1973 | 51 | 0.000 |
Why?
|
Thailand | 1 | 1973 | 287 | 0.000 |
Why?
|
Serologic Tests | 1 | 1973 | 381 | 0.000 |
Why?
|
Dengue | 1 | 1973 | 254 | 0.000 |
Why?
|
Disease Outbreaks | 1 | 1973 | 1749 | 0.000 |
Why?
|